Book a Demo!
CoCalc Logo Icon
StoreFeaturesDocsShareSupportNewsAboutPoliciesSign UpSign In
Download
29548 views
1
2
3
4
5
SECTION 4 QUALITY ASSURANCE
6
7
4.1 INTRODUCTION
8
9
10
4.1.1
11
Development and maintenance of a toxicity test laboratory
12
quality assurance (QA) program (USEPA, 1991b) requires an ongoing
13
commitment by laboratory management. Each toxicity test laboratory
14
should (1) appoint a quality assurance officer with the
15
responsibility and authority to develop and maintain a QA program,
16
(2) prepare a quality assurance plan with stated data quality
17
objectives (DQOs), (3) prepare written descriptions of laboratory
18
standard operating procedures (SOPs) for culturing, toxicity
19
testing, instrument calibration, sample chain-of-custody
20
procedures, laboratory sample tracking system, glassware cleaning,
21
etc., and (4) provide an adequate, qualified technical staff for
22
culturing and toxicity testing the organisms, and suitable space
23
and equipment to assure reliable data.
24
25
26
4.1.2
27
QA practices for toxicity testing laboratories must
28
address all activities that affect the quality of the final
29
effluent toxicity data, such as: (1) effluent sampling and
30
handling; (2) the source and condition of the test organisms; (3)
31
condition of equipment; (4) test conditions; (5) instrument
32
calibration; (6) replication; (7) use of reference toxicants; (8)
33
record keeping; and (9) data evaluation.
34
35
36
4.1.3
37
Quality control practices, on the other hand, consist of
38
the more focused, routine, day-to-day activities carried out within
39
the scope of the overall QA program. For more detailed discussion
40
of quality assurance and general guidance on good laboratory
41
practices and laboratory evaluation related to toxicity testing,
42
see FDA (1978); USEPA (1979d); USEPA (1980b); USEPA (1980c); USEPA
43
(1991c); DeWoskin (1984); and Taylor (1987).
44
45
46
4.1.4
47
Guidelines for the evaluation of laboratory performing
48
toxicity tests and laboratory evaluation criteria are found in
49
USEPA (1991c).
50
51
52
4.2
53
FACILITIES, EQUIPMENT, AND TEST CHAMBERS
54
55
56
57
58
4.2.1
59
Separate test organism culturing and toxicity testing
60
areas should be provided to avoid possible loss of cultures due to
61
cross-contamination. Ventilation systems should be designed and
62
operated to prevent recirculation or leakage of air from chemical
63
analysis laboratories or sample storage and preparation areas into
64
organism culturing or testing areas, and from testing and sample
65
preparation areas into culture rooms.
66
67
68
4.2.2
69
Laboratory and toxicity test temperature control
70
equipment must be adequate to maintain recommended test water
71
temperatures. Recommended materials must be used in the fabrication
72
of the test equipment which comes in contact with the effluent (see
73
Section 5, Facilities, Equipment, and Supplies; and specific
74
toxicity test method).
75
76
77
4.3
78
TEST ORGANISMS
79
80
81
82
83
4.3.1
84
The test organisms used in the procedures described in
85
this manual are the sheepshead minnow, Cyprinodon variegatus; the
86
inland silverside, Menidia beryllina; the mysid, Mysidopsis bahia;
87
the sea urchin, Arbacia punctulata; and the red macroalga, Champia
88
parvula. The organisms used should be disease-free and appear
89
healthy, behave normally, feed well, and have low mortality in
90
cultures, during holding, and in test control. Test organisms
91
should be positively identified to species (see Section 6, Test
92
Organisms).
93
94
95
4.4
96
LABORATORY WATER USED FOR CULTURING AND TEST DILUTION
97
WATER
98
99
100
4.4.1 The quality of water used for test organism culturing and
101
for dilution water used in toxicity tests is extremely important.
102
Water for these two uses should come from the same source. The
103
dilution water used in effluent toxicity tests will depend on the
104
objectives of the study and logistical constraints, as discussed in
105
Section 7, Dilution Water. The dilution water used in the toxicity
106
tests may be natural seawater, hypersaline brine (100‰) prepared
107
from natural seawater, or artificial seawater prepared from
108
commercial sea salts, such as FORTY FATHOMS® or HW MARINEMIX®, if
109
recommended in the method. GP2 synthetic seawater, made from
110
reagent grade chemical salts (30‰) in conjunction with natural
111
seawater, may also be used if recommended. Hypersaline brine and
112
artificial seawater can be used with Champia parvula only if they
113
are accompanied by at least 50% natural seawater. Types of water
114
are discussed in Section 5, Facilities, Equipment, and Supplies.
115
Water used for culturing and test dilution water should be analyzed
116
for toxic metals and organics at least annually or whenever
117
difficulty is encountered in meeting minimum acceptability criteria
118
for control survival and reproduction or growth. The concentration
119
of the metals, Al, As, Cr, Co, Cu, Fe, Pb, Ni, Zn, expressed as
120
total metal, should not exceed 1 µg/L each, and Cd, Hg, and Ag,
121
expressed as total metal, should not exceed 100 ng/L each. Total
122
organochlorine pesticides plus PCBs should be less than 50 ng/L
123
(APHA, 1992). Pesticide concentrations should not exceed USEPA's
124
National Ambient Water Quality chronic criteria values where
125
available.
126
4.5 EFFLUENT AND RECEIVING WATER SAMPLING AND HANDLING
127
128
129
4.5.1
130
Sample holding times and temperatures of effluent samples
131
collected for on-site and off-site testing must conform to
132
conditions described in Section 8, Effluent and Receiving Water
133
Sampling, Sample Handling, and Sample Preparation for Toxicity
134
Tests.
135
136
137
4.6
138
TEST CONDITIONS
139
140
141
142
143
4.6.1
144
Water temperature and salinity should be maintained
145
within the limits specified for each test. The temperature of test
146
solutions must be measured by placing the thermometer or probe
147
directly into the test solutions, or by placing the thermometer in
148
equivalent volumes of water in surrogate vessels positioned at
149
appropriate locations among the test vessels. Temperature should be
150
recorded continuously in at least one vessel during the duration of
151
each test. Test solution temperatures should be maintained within
152
the limits specified for each test. DO concentrations and pH should
153
be checked at the beginning of the test and daily throughout the
154
test period.
155
156
157
4.7
158
QUALITY OF TEST ORGANISMS
159
160
161
162
163
4.7.1
164
The health of test organisms is primarily assessed by the
165
performance (survival, growth, and/or reproduction) of organisms in
166
control treatments of individual tests. The health and sensitivity
167
of test organisms is also assessed by reference toxicant testing.
168
In addition to documenting the sensitivity and health of test
169
organisms, reference toxicant testing is used to initially
170
demonstrate acceptable laboratory performance (Subsection 4.15) and
171
to document ongoing laboratory performance (Subsection
172
4.16).
173
174
175
4.7.2
176
Regardless of the source of test organisms (in-house
177
cultures or purchased from external suppliers), the testing
178
laboratory must perform at least one acceptable reference toxicant
179
test per month for each toxicity test method conducted in that
180
month (Subsection 4.16). If a test method is conducted only
181
monthly, or less frequently, a reference toxicant test must be
182
performed concurrently with each effluent toxicity test.
183
184
185
4.7.3
186
When acute or short-term chronic toxicity tests are
187
performed with effluents or receiving waters using test organisms
188
obtained from outside the test laboratory, concurrent toxicity
189
tests of the same type must be performed with a reference toxicant,
190
unless the test organism supplier provides control chart data from
191
at least the last five monthly short-term chronic toxicity tests
192
using the same reference toxicant and test conditions (see Section
193
6, Test Organisms).
194
195
196
4.7.4
197
The supplier should certify the species identification of
198
the test organisms, and provide the taxonomic reference (citation
199
and page) or name(s) of the taxonomic expert(s)
200
consulted.
201
202
203
4.7.5
204
If a routine reference toxicant test fails to meet test
205
acceptability criteria, then the reference toxicant test must be
206
immediately repeated.
207
208
209
4.8
210
FOOD QUALITY
211
212
213
214
215
4.8.1
216
The nutritional quality of the food used in culturing and
217
testing fish and invertebrates is an important factor in the
218
quality of the toxicity test data. This is especially true for the
219
unsaturated fatty acid content of brine shrimp nauplii, Artemia.
220
Problems with the nutritional suitability of the food will be
221
reflected in the survival, growth, and reproduction of the test
222
organisms in cultures and toxicity tests. Artemia cysts and other
223
foods must be obtained as described in Section 5, Facilities,
224
Equipment, and Supplies.
225
226
227
4.8.2
228
Problems with the nutritional suitability of food will be
229
reflected in the survival, growth, and reproduction of the test
230
organisms in cultures and toxicity tests. If a batch of food is
231
suspected to be defective, the performance of organisms fed with
232
the new food can be compared with the performance of organisms fed
233
with a food of known quality in side-by-side tests. If the food is
234
used for culturing, its suitability should be determined using a
235
short-term chronic test which will determine the affect of food
236
quality on growth or reproduction of each of the relevant test
237
species in culture, using four replicates with each food source.
238
Where applicable, foods used only in chronic toxicity tests can be
239
compared with a food of known quality in side-by-side,
240
multi-concentration chronic tests, using the reference toxicant
241
regularly employed in the laboratory QA program.
242
243
244
4.8.3
245
New batches of food used in culturing and testing should
246
be analyzed for toxic organics and metals or whenever difficulty is
247
encountered in meeting minimum acceptability criteria for control
248
survival and reproduction or growth. If the concentration of total
249
organochlorine pesticides exceeds 0.15 µg/g wet weight, or the
250
concentration of total organochlorine pesticides plus PCBs exceeds
251
0.30 µg/g wet weight, or toxic metals (Al, As, Cr, Cd, Cu, Pb, Ni,
252
Zn, expressed as total metal) exceed 20 µg/g wet weight, the food
253
should not be used (for analytical methods, see AOAC, 1990; and
254
USDA, 1989).
255
256
257
4.84
258
For foods (e.g., YCT) which are used to culture and test
259
organisms, the quality of the food should meet the requirements for
260
the laboratory water used for culturing and test dilution water as
261
described in Section 4.4 above.
262
263
264
4.9
265
ACCEPTABILITY OF CHRONIC TOXICITY TESTS
266
267
268
4.9.1 The results of the sheepshead minnow, Cyprinodon
269
variegatus, inland silverside, Menidia beryllina, or mysid,
270
Mysidopsis bahia, tests are acceptable if survival in the controls
271
is 80% or greater. The sea urchin, Arbacia punctulata, test
272
requires control egg fertilization equal to or exceeding 70%.
273
However, greater than 90% fertilization may result in masking toxic
274
responses. The red macroalga, Champia parvula, test is acceptable
275
if survival is 100%, and the mean number of cystocarps per plant
276
should equal or exceed 10. If the sheepshead minnow, Cyprindon
277
variegatus, larval survival and growth test is begun with
278
less-than-24-h old larvae, the mean dry weight of the surviving
279
larvae in the control chambers at the end of the test must equal or
280
exceed 0.60 mg, if the weights are determined immediately, or
281
282
283
0.50
284
mg if the larvae are preserved in a 4% formalin or 70%
285
ethanol solution. If the inland silverside, Menidia beryllina,
286
larval survival and growth test is begun with larvae seven days
287
old, the mean dry weight of the surviving larvae in the control
288
chambers at the end of the test must equal or exceed 0.50 mg, if
289
the weights are determined immediately, or 0.43 mg if the larvae
290
are preserved in a 4% formalin or 70% ethanol solution. The mean
291
mysid dry weight of survivors must be at least 0.20 mg. Automatic
292
or hourly feeding will generally provide control mysids with a dry
293
weight of 0.30 mg. At least 50% of the females should bear eggs at
294
the end of the test, but mysid fecundity is not a factor in test
295
acceptability. However, fecundity must equal or exceed 50% to be
296
used as an endpoint in the test. If these criteria are not met, the
297
test must be repeated.
298
299
300
4.9.2
301
An individual test may be conditionally acceptable if
302
temperature, DO, and other specified conditions fall outside
303
specifications, depending on the degree of the departure and the
304
objectives of the tests (see test conditions and test acceptability
305
criteria summaries). The acceptability of the test will depend on
306
the experience and professional judgment of the laboratory
307
investigator and the reviewing staff of the regulatory authority.
308
Any deviation from test specifications must be noted when reporting
309
data from a test.
310
311
312
4.10 ANALYTICAL METHODS
313
314
315
4.10.1
316
Routine chemical and physical analyses for culture and
317
dilution water, food, and test solutions must include established
318
quality assurance practices outlined in USEPA methods manuals
319
(USEPA, 1979a and USEPA, 1979b).
320
321
322
4.10.2
323
Reagent containers should be dated and catalogued when
324
received from the supplier, and the shelf life should not be
325
exceeded. Also, working solutions should be dated when prepared,
326
and the recommended shelf life should be observed.
327
328
329
4.11
330
CALIBRATION AND STANDARDIZATION
331
332
333
334
335
4.11.1
336
Instruments used for routine measurements of chemical and
337
physical parameters, such as pH, DO, temperature, conductivity, and
338
salinity, must be calibrated and standardized according to
339
instrument manufacturers procedures as indicated in the general
340
section on quality assurance (see USEPA Methods 150.1, 360.1,
341
170.1, and 120.1 in USEPA, 1979b). Calibration data are recorded in
342
a permanent log book.
343
344
345
4.11.2
346
Wet chemical methods used to measure hardness,
347
alkalinity, and total residual chlorine, must be standardized prior
348
to use each day according to the procedures for those specific
349
USEPA methods (see USEPA Methods 130.2 and 310.1 in USEPA,
350
1979b).
351
352
353
4.12
354
REPLICATION AND TEST SENSITIVITY
355
356
357
358
359
4.12.1
360
The sensitivity of the tests will depend in part on the
361
number of replicates per concentration, the significance level
362
selected, and the type of statistical analysis. If the variability
363
remains constant, the sensitivity of the test will increase as the
364
number of replicates is increased. The minimum recommended number
365
of replicates varies with the objectives of the test and the
366
statistical method used for analysis of the data.
367
368
369
4.13
370
VARIABILITY IN TOXICITY TEST RESULTS
371
372
373
374
375
4.13.1
376
Factors which can affect test success and precision
377
include: (1) the experience and skill of the laboratory analyst;
378
(2) test organism age, condition, and sensitivity; (3) dilution
379
water quality; (4) temperature control; (5) and the quality and
380
quantity of food provided. The results will depend upon the species
381
used and the strain or source of the test organisms, and test
382
conditions, such as temperature, DO, food, and water quality. The
383
repeatability or precision of toxicity tests is also a function of
384
the number of test organisms used at each toxicant concentration.
385
Jensen (1972) discussed the relationship between sample size
386
(number of fish) and the standard error of the test, and considered
387
20 fish per concentration as optimum for Probit
388
Analysis.
389
390
391
4.14
392
TEST PRECISION
393
394
395
396
397
4.14.1
398
The ability of the laboratory personnel to obtain
399
consistent, precise results must be demonstrated with reference
400
toxicants before they attempt to measure effluent toxicity. The
401
single-laboratory precision of each type of test to be used in a
402
laboratory should be determined by performing at least five or more
403
tests with a reference toxicant.
404
405
406
4.14.2
407
Test precision can be estimated by using the same strain
408
of organisms under the same test conditions, and employing a known
409
toxicant, such as a reference toxicant.
410
411
412
4.14.3
413
Interlaboratory precision data from a 1991 study of
414
chronic toxicity tests using two reference toxicants with the
415
mysid, Mysidopsis bahia, and the inland silverside, Menidia
416
beryllina, is listed in Table 1. Table 2 shows interlaboratory
417
precision data from a study of three chronic toxicity test methods
418
using effluent, receiving water, and reference toxicant sample
419
types (USEPA, 2001a; USEPA, 2001b). For the Mysidopsis bahia and
420
the Cyprinodon variegatus test methods, the effluent sample was a
421
municipal wastewater spiked with KCl, the receiving water sample
422
was a river water spiked with KCl, and the reference toxicant
423
sample was bioassay-grade FORTY FATHOMS®
424
425
426
synthetic seawater spiked with KCl. For the Menidia beryllina
427
test method, the effluent sample was an industrial wastewater
428
spiked with CuSO4, the receiving water sample was a natural
429
seawater spiked with CuSO4, and the reference toxicant sample was
430
bioassay-grade FORTY FATHOMS® synthetic seawater spiked with CuSO4.
431
Additional precision data for each of the tests described in this
432
manual are presented in the sections describing the individual test
433
methods.
434
435
436
4.14.4
437
Additional information on toxicity test precision is
438
provided in the Technical Support Document for Water Quality-based
439
Toxic Control (see pp. 2-4, and 11-15 in USEPA, 1991a).
440
441
442
4.14.5
443
In cases where the test data are used in Probit Analysis
444
or other point estimation techniques (see Section 9, Chronic
445
Toxicity Test Endpoints and Data Analysis), precision can be
446
described by the mean, standard deviation, and relative standard
447
deviation (percent coefficient of variation, or CV) of the
448
calculated endpoints from the replicated tests. In cases where the
449
test data are used in the Linear Interpolation Method, precision
450
can be estimated by empirical confidence intervals derived by using
451
the ICPIN Method (see Section 9, Chronic Toxicity Test Endpoints
452
and Data Analysis). However, in cases where the results are
453
reported in terms of the No-Observed-Effect-Concentration (NOEC)
454
and Lowest-Observed-Effect-Concentration (LOEC) (see Section 9,
455
Chronic Toxicity Test Endpoints and Data Analysis), precision can
456
only be described by listing the NOEC-LOEC interval for each test.
457
It is not possible to express precision in terms of a commonly used
458
statistic. However, when all tests of the same toxicant yield the
459
same NOEC-LOEC interval, maximum precision has been attained. The
460
"true" no effect concentration could fall anywhere within the
461
interval, NOEC ± (LOEC minus NOEC).
462
463
464
4.14.6
465
It should be noted here that the dilution factor selected
466
for a test determines the width of the NOEC-LOEC interval and the
467
inherent maximum precision of the test. As the absolute value of
468
the dilution factor decreases, the width of the NOEC-LOEC interval
469
increases, and the inherent maximum precision of the test
470
decreases. When a dilution factor of 0.3 is used, the NOEC could be
471
considered to have a relative uncertainty as high as ± 300%. With a
472
dilution factor of 0.5, the NOEC could be considered to have a
473
relative variability of ± 100%. As a result of the variability of
474
different dilution factors, USEPA recommends the use of a $ 0.5
475
dilution factor. Other factors which can affect test precision
476
include: test organism age, condition, and sensitivity; temperature
477
control; and feeding.
478
479
480
TABLE 1. NATIONAL INTERLABORATORY STUDY OF CHRONIC TOXICITY TEST
481
PRECISION, 1991: SUMMARY OF RESPONSES USING TWO REFERENCE
482
TOXICANTS1,2
483
4
484
Organism Endpoint No. Labs KCl(mg/L)SD CV(%)3
485
Mysidopsis Survival, NOEC
486
bahia Growth, IC25 Growth, IC50 Growth, NOEC Fecundity, NOEC 34
487
NA NANA 26 480 3.47 28.9 22 656 3.17 19.3 32 NA NANA 25 NA NANA
488
Organism Endpoint No. Labs Cu(mg/L)4 SD CV(%)3
489
Menidia Survival, NOEC
490
beryllina Growth, IC25 Growth, IC50 Growth, NOEC 19 NA NANA 13
491
0.144 1.56 43.5 12 0.180 1.87 41.6 17 NA NANA
492
1
493
From a national study of interlaboratory precision of toxicity
494
test data performed in 1991 by the Environmental Monitoring Systems
495
Laboratory-Cincinnati, U.S. Environmental Protection Agency,
496
Cincinnati, OH 45268. Participants included federal, state, and
497
private laboratories engaged in NPDES permit compliance
498
monitoring.
499
2
500
Static renewal test, using 25 ‰ modified GP2 artificial
501
seawater.
502
3
503
Percent coefficient of variation = (standard deviation X
504
100)/mean.
505
4
506
Expressed as mean.
507
TABLE 2. NATIONAL INTERLABORATORY STUDY OF CHRONIC TOXICITY TEST
508
PRECISION, 2000: PRECISION OF RESPONSES USING EFFLUENT, RECEIVING
509
WATER, AND REFERENCE TOXICANT SAMPLE TYPES1
510
511
1
512
From EPA's WET Interlaboratory Variability Study (USEPA, 2001a;
513
USEPA, 2001b).
514
2
515
Represents the number of valid tests (i.e., those that met test
516
acceptability criteria) that were used in the analysis of
517
precision. Invalid tests were not used.
518
3
519
CVs based on total interlaboratory variability (including both
520
within-laboratory and between-laboratory components of variability)
521
and averaged across sample types. IC25s or IC50s were pooled for
522
all laboratories to calculate the CV for each sample type. The
523
resulting CVs were then averaged across sample types.
524
4.15 DEMONSTRATING ACCEPTABLE LABORATORY
525
PERFORMANCE
526
527
528
4.15.1
529
It is a laboratory's responsibility
530
to demonstrate its ability to obtain consistent, precise results
531
with reference toxicants before it performs toxicity tests with
532
effluents for permit compliance purposes. To meet this requirement,
533
the intralaboratory precision, expressed as percent coefficient of
534
variation (CV%), of each type of test to be used in a laboratory
535
should be determined by performing five or more tests with
536
different batches of test organisms, using the same reference
537
toxicant, at the same concentrations, with the same test conditions
538
(i.e., the same test duration, type of dilution water, age of test
539
organisms, feeding, etc.), and same data analysis methods. A
540
reference toxicant concentration series (0.5 or higher) should be
541
selected that will consistently provide partial mortalities at two
542
or more concentrations.
543
544
545
4.16
546
DOCUMENTING ONGOING LABORATORY PERFORMANCE
547
548
549
550
551
4.16.1
552
Satisfactory laboratory performance is demonstrated by
553
performing at least one acceptable test per month with a reference
554
toxicant for each toxicity test method conducted in the laboratory
555
during that month. For a given test method, successive tests must
556
be performed with the same reference toxicant, at the same
557
concentrations, in the same dilution water, using the same data
558
analysis methods. Precision may vary with the test species,
559
reference toxicant, and type of test. Each laboratory's reference
560
toxicity data will reflect conditions unique to that facility,
561
including dilution water, culturing, and other variables; however,
562
each laboratory's reference toxicity results should reflect good
563
repeatability.
564
565
566
4.16.2
567
A control chart should be prepared for each combination
568
of reference toxicant, test species, test conditions, and
569
endpoints. Toxicity endpoints from five or six tests are adequate
570
for establishing the control charts. Successive toxicity endpoints
571
(NOECs, IC25s, LC50s, etc.) should be plotted and examined to
572
determine if the results (X1) are within prescribed limits (Figure
573
1). The chart should plot logarithm of concentration on the
574
vertical axis against the date of the test or test number on the
575
horizontal axis. The types of control charts illustrated (see
576
USEPA, 1979a) are used to evaluate the cumulative trend of results
577
from a series of samples, thus reference toxicant test results
578
should not be used as a de facto criterion for rejection of
579
individual effluent or receiving water tests. For endpoints that
580
are point estimates (LC50s and IC25s), the cumulative mean (X¯) and
581
upper and lower control limits (± 2S) are re-calculated with each
582
successive test result. Endpoints from hypothesis tests (NOEC,
583
NOAEC) from each test are plotted directly on the control chart.
584
The control limits would consist of one concentration interval
585
above and below the concentration representing the central
586
tendency. After two years of data collection, or a minimum of 20
587
data points, the control chart should be maintained using only the
588
20 most recent data points.
589
590
591
4.16.3
592
Laboratories should compare the calculated CV (i.e.,
593
standard deviation / mean) of the IC25 for the 20 most recent data
594
points to the distribution of laboratory CVs reported nationally
595
for reference toxicant testing (Table 3-2 in USEPA, 2000b). If the
596
calculated CV exceeds the 75th percentile of CVs reported
597
nationally, the laboratory should use the 75th and 90th percentiles
598
to calculate warning and control limits, respectively, and the
599
laboratory should investigate options for reducing variability.
600
Note: Because NOECs can only be a fixed number of discrete values,
601
the mean, standard deviation, and CV cannot be interpreted and
602
applied in the same way that these descriptive statistics are
603
interpreted and applied for continuous variables such as the IC25
604
or LC50.
605
606
607
608
4.16.4
609
The outliers, which are values falling outside the upper
610
and lower control limits, and trends of increasing or decreasing
611
sensitivity, are readily identified. In the case of endpoints that
612
are point estimates (LC50s and IC25s), at the 0.05 probability
613
level, one in 20 tests would be expected to fall outside of the
614
control limits by chance alone. If more than one out of 20
615
reference toxicant tests fall outside the control limits, the
616
laboratory should investigate sources of variability, take
617
corrective actions to reduce identified sources of variability, and
618
perform an additional reference toxicant test during the same
619
month. Control limits for the NOECs will also be exceeded
620
occasionally, regardless of how well a laboratory performs. In
621
those instances when the laboratory can document the cause for the
622
outlier (e.g., operator error, culture health or test system
623
failure), the outlier should be excluded from the future
624
calculations of the
625
626
627
control limits. If two or more consecutive tests do not fall
628
within the control limits, the results must be explained and the
629
reference toxicant test must be immediately repeated. Actions taken
630
to correct the problem must be reported.
631
632
633
4.16.5
634
If the toxicity value from a given test with a reference
635
toxicant fall well outside the expected range for the test
636
organisms when using the standard dilution water and other test
637
conditions, the laboratory should investigate sources of
638
variability, take corrective actions to reduce identified sources
639
of variability, and perform an additional reference toxicant test
640
during the same month. Performance should improve with experience,
641
and the control limits for endpoints that are point estimates
642
should gradually narrow. However, control limits of ± 2S will be
643
exceeded 5% of the time by chance alone, regardless of how well a
644
laboratory performs. Highly proficient laboratories which develop
645
very narrow control limits may be unfairly penalized if a test
646
result which falls just outside the control limits is rejected de
647
facto. For this reason, the width of the control limits should be
648
considered in determining whether or not a reference toxicant test
649
result falls "well" outside the expected range. The width of the
650
control limits may be evaluated by comparing the calculated CV
651
(i.e., standard deviation / mean) of the IC25 for the 20 most
652
recent data points to the distribution of laboratory CVs reported
653
nationally for reference toxicant testing (Table 3-2 in USEPA,
654
2000b). In determining whether or not a reference toxicant test
655
result falls "well" outside the expected range, the result also may
656
be compared with upper and lower bounds for ± 3S, as any result
657
outside these control limits would be expected to occur by chance
658
only 1 out of 100 tests (Environment Canada, 1990). When a result
659
from a reference toxicant test is outside the 99% confidence
660
intervals, the laboratory must conduct an immediate investigation
661
to assess the possible causes for the outlier.
662
663
664
4.16.6
665
Reference toxicant test results
666
should not be used as a de facto criterion for rejection of
667
individual effluent or receiving water tests. Reference toxicant
668
testing is used for evaluating the health and sensitivity of
669
organisms over time and for documenting initial and ongoing
670
laboratory performance. While reference toxicant test results
671
should not be used as a de facto criterion for test rejection,
672
effluent and receiving water test results should be reviewed and
673
interpreted in the light of reference toxicant test results. The
674
reviewer should consider the degree to which the reference toxicant
675
test result fell outside of control chart limits, the width of the
676
limits, the direction of the deviation (toward increased test
677
organism sensitivity or toward decreased test organism
678
sensitivity), the test conditions of both the effluent test and the
679
reference toxicant test, and the objective of the test.
680
681
682
4.17
683
REFERENCE TOXICANTS
684
685
686
687
688
4.17.1
689
Reference toxicants such as sodium chloride (NaCl),
690
potassium chloride (KCl), cadmium chloride (CdCl2), copper sulfate
691
(CuSO4), sodium dodecyl sulfate (SDS), and potassium dichromate
692
(K2Cr2O7), are suitable for use in the NPDES Program and other
693
Agency programs requiring aquatic toxicity tests. EMSL-Cincinnati
694
plans to release USEPA-certified solutions of cadmium and copper
695
for use as reference toxicants, through cooperative research and
696
development agreements with commercial suppliers, and will continue
697
to develop additional reference toxicants for future release.
698
Standard reference materials can be obtained from commercial supply
699
houses, or can be prepared inhouse using reagent grade chemicals.
700
The regulatory agency should be consulted before reference
701
toxicant(s) are selected and used.
702
703
704
4.18
705
RECORD KEEPING
706
707
708
709
710
711
4.18.1
712
Proper record keeping is important. A complete file must
713
be maintained for each individual toxicity test or group of tests
714
on closely related samples. This file must contain a record of the
715
sample chain-of-custody; a copy of the sample log sheet; the
716
original bench sheets for the test organism responses during the
717
toxicity test(s); chemical analysis data on the sample(s); detailed
718
records of the test organisms used in the test(s), such as species,
719
source, age, date of receipt, and other pertinent information
720
relating to their history and health; information on the
721
calibration of equipment and instruments; test conditions employed;
722
and results of reference toxicant tests. Laboratory data should be
723
recorded on a real-time basis to prevent the loss of information or
724
inadvertent introduction of errors into the record. Original data
725
sheets should be signed and dated by the laboratory personnel
726
performing the tests.
727
728
729
4.18.2
730
The regulatory authority should retain records pertaining
731
to discharge permits. Permittees are required to retain records
732
pertaining to permit applications and compliance for a minimum of 3
733
years [40 CFR 122.41(j)(2)].
734
735
736
SECTION 5
737
FACILITIES, EQUIPMENT, AND SUPPLIES
738
5.1 GENERAL REQUIREMENTS
739
740
741
5.1.1
742
Effluent toxicity tests may be performed in a fixed or
743
mobile laboratory. Facilities must include equipment for rearing
744
and/or holding organisms. Culturing facilities for test organisms
745
may be desirable in fixed laboratories which perform large numbers
746
of tests. Temperature control can be achieved using circulating
747
water baths, heat exchangers, or environmental chambers. Water used
748
for rearing, holding, acclimating, and testing organisms may be
749
natural seawater or water made up from hypersaline brine derived
750
from natural seawater, or water made up from reagent grade
751
chemicals (GP2) or commercial (FORTY FATHOMS® or HW MARINEMIX®)
752
artificial sea salts when specifically recommended in the method.
753
Air used for aeration must be free of oil and toxic vapors.
754
Oil-free air pumps should be used where possible. Particulates can
755
be removed from the air using BALSTON® Grade BX or equivalent
756
filters, and oil and other organic vapors can be removed using
757
activated carbon filters (BALSTON®, C-1 filter, or
758
equivalent).
759
760
761
5.1.2
762
The facilities must be well ventilated and free of fumes.
763
Laboratory ventilation systems should be checked to ensure that
764
return air from chemistry laboratories and/or sample handling areas
765
is not circulated to test organism culture rooms or toxicity test
766
rooms, or that air from toxicity test rooms does not contaminate
767
culture areas. Sample preparation, culturing, and toxicity testing
768
areas should be separated to avoid cross-contamination of cultures
769
or toxicity test solutions with toxic fumes. Air pressure
770
differentials between such rooms should not result in a net flow of
771
potentially contaminated air to sensitive areas through open or
772
loosely-fitting doors. Organisms should be shielded from external
773
disturbances.
774
775
776
5.1.3
777
Materials used for exposure chambers, tubing, etc., which
778
come in contact with the effluent and dilution water, should be
779
carefully chosen. Tempered glass and perfluorocarbon plastics
780
(TEFLON®) should be used whenever possible to minimize sorption and
781
leaching of toxic substances. These materials may be reused
782
following decontamination. Containers made of plastics, such as
783
polyethylene, polypropylene, polyvinyl chloride, TYGON®, etc., may
784
be used as test chambers or to ship, store, and transfer effluents
785
and receiving waters, but they should not be reused unless
786
absolutely necessary, because they might carry over adsorbed
787
toxicants from one test to another, if reused. However, these
788
containers may be repeatedly reused for storing uncontaminated
789
waters such as deionized or laboratory-prepared dilution waters and
790
receiving waters. Glass or disposable polystyrene containers can be
791
used as test chambers. The use of large ($20 L) glass carboys is
792
discouraged for safety reasons.
793
794
795
5.1.4
796
New plastic products of a type not previously used should
797
be tested for toxicity before initial use by exposing the test
798
organisms in the test system where the material is used. Equipment
799
(pumps, valves, etc.) which cannot be discarded after each use
800
because of cost, must be decontaminated according to the cleaning
801
procedures listed below (see Section 5, Facilities, Equipment, and
802
Supplies, Subsection 5.3.2). Fiberglass, in addition to the
803
previously mentioned materials, can be used for holding,
804
acclimating, and dilution water storage tanks, and in the water
805
delivery system, but once contaminated with pollutants the
806
fiberglass should not be reused. All material should be flushed or
807
rinsed thoroughly with the test media before using in the
808
test.
809
810
811
5.1.5
812
Copper, galvanized material, rubber, brass, and lead must
813
not come in contact with culturing, holding, acclimation, or
814
dilution water, or with effluent samples and test solutions. Some
815
materials, such as several types of neoprene rubber (commonly used
816
for stoppers) may be toxic and should be tested before
817
use.
818
819
820
5.1.6
821
Silicone adhesive used to construct glass test chambers
822
absorbs some organochlorine and organophosphorus pesticides, which
823
are difficult to remove. Therefore, as little of the adhesive as
824
possible should be in contact with water. Extra beads of adhesive
825
inside the containers should be removed.
826
827
828
5.2
829
TEST CHAMBERS
830
831
832
833
834
5.2.1
835
Test chamber size and shape are varied according to size
836
of the test organism. Requirements are specified in each toxicity
837
test method.
838
839
840
5.3
841
CLEANING TEST CHAMBERS AND LABORATORY
842
APPARATUS
843
844
845
846
847
5.3.1
848
New plasticware used for sample collection or organism
849
exposure vessels generally does not require thorough cleaning
850
before use. It is sufficient to rinse new sample containers once
851
with dilution water before use. New, disposable, plastic test
852
chambers may have to be rinsed with dilution water before use. New
853
glassware must be soaked overnight in 10% acid (see below) and also
854
should be rinsed well in deionized water and seawater.
855
856
857
858
5.3.2
859
All non-disposable sample containers, test vessels,
860
pumps, tanks, and other equipment that has come in contact with
861
effluent must be washed after use to remove surface contaminants,
862
as described below.
863
864
865
866
1.
867
Soak 15 minutes in tap water and scrub with detergent, or
868
clean in an automatic dishwasher.
869
870
871
2.
872
Rinse twice with tap water.
873
874
875
3.
876
Carefully rinse once with fresh dilute (10% V:V)
877
hydrochloric acid or nitric acid to remove scale, metals and bases.
878
To prepare a 10% solution of acid, add 10 mL of concentrated acid
879
to 90 mL of deionized water.
880
881
882
4.
883
Rinse twice with deionized water.
884
885
886
5.
887
Rinse once with full-strength, pesticide-grade acetone to
888
remove organic compounds (use a fume hood or canopy).
889
890
891
6.
892
Rinse three times with deionized water.
893
894
895
896
897
898
899
5.3.3
900
All test chambers and equipment must be thoroughly rinsed
901
with the dilution water immediately prior to use in each
902
test.
903
904
905
5.4
906
APPARATUS AND EQUIPMENT FOR CULTURING AND TOXICITY
907
TESTS
908
909
910
911
912
5.4.1
913
Apparatus and equipment requirements for culturing and
914
toxicity tests are specified in each toxicity test method. Also,
915
see USEPA, 2002a.
916
917
918
5.4.2
919
WATER PURIFICATION SYSTEM
920
921
922
923
924
5.4.2.1
925
A good quality, laboratory grade
926
deionized water, providing a resistance of 18 megaohm-cm, must be
927
available in the laboratory and in sufficient quantity for
928
laboratory needs. Deionized water may be obtained from MILLIPORE®,
929
MILLI-Q®, MILLIPORE® QPAK™2 or equivalent system. If large
930
quantities of high quality deionized water are needed, it may be
931
advisable to supply the laboratory grade water deionizer with
932
preconditioned water from a Culligan®, Continental®, or equivalent
933
mixed-bed water treatment system.
934
935
936
5.5
937
REAGENTS AND CONSUMABLE MATERIALS
938
939
940
5.5.1 SOURCES OF FOOD FOR CULTURE AND TOXICITY TESTS
941
942
943
1.
944
Brine Shrimp, Artemia sp. cysts -- Many commercial
945
sources of brine shrimp cysts are available.
946
947
948
2.
949
Frozen Adult Brine Shrimp, Artemia -- Available from most
950
pet supply shops or other commercial sources.
951
952
953
3.
954
Flake Food -- TETRAMIN® and BIORIL® or equivalent are
955
available at most pet supply shops.
956
957
958
4.
959
Feeding requirements and other specific foods are
960
indicated in the specific toxicity test method.
961
962
963
964
965
5.5.1.1
966
All food should be tested for nutritional suitability and
967
chemically analyzed for organochlorine pesticides, PCBs, and toxic
968
metals (see Section 4, Quality Assurance).
969
970
971
5.5.2
972
Reagents and consumable materials are specified in each
973
toxicity test method. Also, see Section 4, Quality
974
Assurance.
975
976
977
5.6
978
TEST ORGANISMS
979
980
981
982
983
5.6.1
984
Test organisms are obtained from inhouse cultures or
985
commercial suppliers (see specific toxicity test method; Sections
986
4, Quality Assurance and 6, Test Organisms).
987
988
989
5.7
990
SUPPLIES
991
992
993
5.7.1 See toxicity test methods (see Sections 11-16) for
994
specific supplies.
995
SECTION 6
996
TEST ORGANISMS
997
6.1 TEST SPECIES
998
999
1000
6.1.1
1001
The species used in characterizing the chronic toxicity
1002
of effluents and/or receiving waters will depend on the
1003
requirements of the regulatory authority and the objectives of the
1004
test. It is essential that good quality test organisms be readily
1005
available throughout the year from inhouse or commercial sources to
1006
meet NPDES monitoring requirements. The organisms used in toxicity
1007
tests must be identified to species. If there is any doubt as to
1008
the identity of the test organisms, representative specimens should
1009
be sent to a taxonomic expert to confirm the
1010
identification.
1011
1012
1013
6.1.2
1014
Toxicity test conditions and culture methods for the
1015
species listed in Subsection 6.1.3 are provided in this manual
1016
(also, see USEPA, 2002a).
1017
1018
1019
6.1.3
1020
The organisms used in the short-term tests described in
1021
this manual are the sheepshead minnow, Cyprinodon variegatus; the
1022
inland silverside, Menidia beryllina; the mysid, Mysidopsis bahia;
1023
the sea urchin, Arbacia punctulata; and the red macroalga, Champia
1024
parvula.
1025
1026
1027
6.1.4
1028
Some states have developed culturing and testing methods
1029
for indigenous species that may be as sensitive or more sensitive,
1030
than the species recommended in Subsection 6.1.3. However, USEPA
1031
allows the use of indigenous species only where state regulations
1032
require their use or prohibit importation of the species in
1033
Subsection 6.1.3. Where state regulations prohibit importation of
1034
non-native fishes or use of the recommended test species,
1035
permission must be requested from the appropriate state agency
1036
prior to their use.
1037
1038
1039
6.1.5
1040
Where states have developed culturing and testing methods
1041
for indigenous species other than those recommended in this manual,
1042
data comparing the sensitivity of the substitute species and one or
1043
more of the recommended species must be obtained in side-by-side
1044
toxicity tests with reference toxicants and/or effluents, to ensure
1045
that the species selected are at least as sensitive as the
1046
recommended species. These data must be submitted to the permitting
1047
authority (State or Region) if required. USEPA acknowledges that
1048
reference toxicants prepared from pure chemicals may not always be
1049
representative of effluents. However, because of the observed
1050
and/or potential variability in the quality and toxicity of
1051
effluents, it is not possible to specify a representative
1052
effluent.
1053
1054
1055
1056
6.1.6
1057
Guidance for the selection of test
1058
organisms where the salinity of the effluent and/or receiving water
1059
requires special consideration is provided in the Technical Support
1060
Document for Water Quality-based Toxics Control (USEPA,
1061
1991a).
1062
1063
1064
1065
1.
1066
Where the salinity of the receiving water is < 1‰,
1067
freshwater organisms are used regardless of the salinity of the
1068
effluent.
1069
1070
1071
2.
1072
Where the salinity of the receiving water is $1‰, the
1073
choice of organisms depends on state water quality standards and/or
1074
permit requirements.
1075
1076
1077
1078
1079
6.2
1080
SOURCES OF TEST ORGANISMS
1081
1082
1083
1084
1085
6.2.1
1086
The test organisms recommended in this manual can be
1087
cultured in the laboratory using culturing and handling methods for
1088
each organism described in the respective test method sections.
1089
Also, see USEPA (2002a).
1090
1091
1092
6.2.2
1093
Inhouse cultures should be established wherever it is
1094
cost effective. If inhouse cultures cannot be maintained or it is
1095
not cost effective, test organisms should be purchased from
1096
experienced commercial suppliers (see USEPA, 1993b).
1097
1098
1099
6.2.3
1100
Sheepshead minnows, inland silversides, mysids, and sea
1101
urchins may be purchased from commercial suppliers. However, some
1102
of these organisms (e.g., adult sheepshead minnows or adult inland
1103
silversides) may not always be available from commercial suppliers
1104
and may have to be collected in the field and brought back to the
1105
laboratory for spawning to obtain eggs and larvae.
1106
1107
1108
6.2.4
1109
If, because of their source, there is any uncertainty
1110
concerning the identity of the organisms, it is advisable to have
1111
them examined by a taxonomic specialist to confirm their
1112
identification. For detailed guidance on identification, see the
1113
individual toxicity test methods.
1114
1115
1116
6.2.5
1117
FERAL (NATURAL OCCURRING, WILD CAUGHT)
1118
ORGANISMS
1119
1120
1121
6.2.5.1 The use of test organisms taken from the receiving water
1122
has strong appeal, and would seem to be the logical approach.
1123
However, it is generally impractical and not recommended for the
1124
following reasons:
1125
1126
1127
1.
1128
Sensitive organisms may not be present in the receiving
1129
water because of previous exposure to the effluent or other
1130
pollutants.
1131
1132
1133
2.
1134
It is often difficult to collect organisms of the
1135
required age and quality from the receiving water.
1136
1137
1138
3.
1139
Most states require collection permits, which may be
1140
difficult to obtain. Therefore, it is usually more cost effective
1141
to culture the organisms in the laboratory or obtain them from
1142
private, state, or Federal sources. Fish such as sheepshead minnows
1143
and silversides, and invertebrates such as mysids, are easily
1144
reared in the laboratory or purchased.
1145
1146
1147
4.
1148
The required QA/QC records, such as the single-laboratory
1149
precision data, would not be available.
1150
1151
1152
5.
1153
Since it is mandatory that the identity of test organisms
1154
is known to the species level, it would be necessary to examine
1155
each organism caught in the wild to confirm its identity, which
1156
would usually be impractical or, at the least, very stressful to
1157
the organisms.
1158
1159
1160
6.
1161
Test organisms obtained from the wild must be observed in
1162
the laboratory for a minimum of one week prior to use, to ensure
1163
that they are free of signs of parasitic or bacterial infections
1164
and other adverse effects. Fish captured by electroshocking must
1165
not be used in toxicity testing.
1166
1167
1168
1169
1170
6.2.5.2
1171
Guidelines for collection of natural occurring organisms
1172
are provided in USEPA (1973); USEPA (1990a); and USEPA
1173
(1993b).
1174
1175
1176
6.2.6
1177
Regardless of their source, test organisms should be
1178
carefully observed to ensure that they are free of signs of stress
1179
and disease, and in good physical condition. Some species of test
1180
organisms, such as trout, can be obtained from stocks certified as
1181
"disease-free."
1182
1183
1184
6.3
1185
LIFE STAGE
1186
1187
1188
1189
1190
6.3.1
1191
Young organisms are often more sensitive to toxicants
1192
than are adults. For this reason, the use of early life stages,
1193
such as juvenile mysids and larval fish, is required for all tests.
1194
In a given test, all organisms should be approximately the same age
1195
and should be taken from the same source. Since age may affect the
1196
results of the tests, it would enhance the value and comparability
1197
of the data if the same species in the same life stages were used
1198
throughout a monitoring program at a given facility.
1199
1200
1201
6.4
1202
LABORATORY CULTURING
1203
1204
1205
1206
1207
6.4.1
1208
Instructions for culturing and/or holding the recommended
1209
test organisms are included in specified test methods (also, see
1210
USEPA, 2002a).
1211
1212
1213
6.5
1214
HOLDING AND HANDLING TEST ORGANISMS
1215
1216
1217
1218
1219
6.5.1
1220
Test organisms should not be subjected to changes of more
1221
than 3°C in water temperature or 3‰ in salinity in any 12 h
1222
period.
1223
1224
1225
6.5.2
1226
Organisms should be handled as little as possible. When
1227
handling is necessary, it should be done as gently, carefully, and
1228
quickly as possible to minimize stress. Organisms that are dropped
1229
or touch dry surfaces or are injured during handling must be
1230
discarded. Dipnets are best for handling larger organisms. These
1231
nets are commercially available or can be made from small-mesh
1232
nylon netting, silk bolting cloth, plankton netting, or similar
1233
material. Wide-bore, smooth glass tubes (4 to 8 mm ID) with rubber
1234
bulbs or pipettors (such as a PROPIPETTE® or other pipettor) should
1235
be used for transferring smaller organisms such as mysids, and
1236
larval fish.
1237
1238
1239
6.5.3
1240
Holding tanks for fish are supplied with a good quality
1241
water (see Section 5, Facilities, Equipment, and Supplies) with a
1242
flow-through rate of at least two tank-volumes per day. Otherwise,
1243
use a recirculation system where the water flows through an
1244
activated carbon or undergravel filter to remove dissolved
1245
metabolites. Culture water can also be piped through high intensity
1246
ultraviolet light sources for disinfection, and to photo-degrade
1247
dissolved organics.
1248
1249
1250
6.5.4
1251
Crowding should be avoided because it will stress the
1252
organisms and lower the DO concentrations to unacceptable levels.
1253
The DO must be maintained at a minimum of 4.0 mg/L. The solubility
1254
of oxygen depends on temperature, salinity, and altitude. Aerate
1255
gently if necessary.
1256
1257
1258
6.5.5
1259
The organisms should be observed carefully each day for
1260
signs of disease, stress, physical damage, or mortality. Dead and
1261
abnormal organisms should be removed as soon as observed. It is not
1262
uncommon for some fish mortality (510%) to occur during the first
1263
48 h in a holding tank because of individuals that refuse to feed
1264
on artificial food and die of starvation. Organisms in the holding
1265
tanks should generally be fed as in the cultures (see culturing
1266
methods in the respective methods).
1267
1268
1269
6.5.6
1270
Fish should be fed as much as they will eat at least once
1271
a day with live brine shrimp nauplii, Artemia, or frozen adult
1272
brine shrimp or dry food (frozen food should be completely thawed
1273
before use). Adult brine shrimp can be supplemented with
1274
commercially prepared food such as TETRAMIN® or BIORIL® flake food,
1275
or equivalent. Excess food and fecal material should be removed
1276
from the bottom of the tanks at least twice a week by
1277
siphoning.
1278
1279
1280
6.5.7
1281
A daily record of feeding, behavioral observations, and
1282
mortality should be maintained.
1283
1284
1285
6.6
1286
TRANSPORTATION TO THE TEST SITE
1287
1288
1289
1290
1291
6.6.1
1292
Organisms are transported from the base or supply
1293
laboratory to a remote test site in culture water or standard
1294
dilution water in plastic bags or large-mouth screw-cap (500 mL)
1295
plastic bottles in styrofoam coolers. Adequate DO is maintained by
1296
replacing the air above the water in the bags with oxygen from a
1297
compressed gas cylinder, and sealing the bags. Another method
1298
commonly used to maintain sufficient DO during shipment is to
1299
aerate with an airstone which is supplied from a portable pump. The
1300
DO concentration must not fall below 4.0 mg/L.
1301
1302
1303
6.6.2
1304
Upon arrival at the test site, organisms are transferred
1305
to receiving water if receiving water is to be used as the test
1306
dilution water. All but a small volume of the holding water
1307
(approximately 5%) is removed by siphoning, and replaced slowly
1308
over a 10 to 15 minute period with dilution water. If receiving
1309
water is used as dilution water, caution must be exercised in
1310
exposing the test organisms to it, because of the possibility that
1311
it might be toxic. For this reason, it is recommended that only
1312
approximately 10% of the test organisms be exposed initially to the
1313
dilution water. If this group does not show excessive mortality or
1314
obvious signs of stress in a few hours, the remainder of the test
1315
organisms are transferred to the dilution water.
1316
1317
1318
6.6.3
1319
A group of organisms must not be used for a test if they
1320
appear to be unhealthy, discolored, or otherwise stressed, or if
1321
mortality appears to exceed 10% preceding the test. If the
1322
organisms fail to meet these criteria, the entire group must be
1323
discarded and a new group obtained. The mortality may be due to the
1324
presence of toxicity, if receiving
1325
1326
1327
water is used as dilution water, rather than a diseased
1328
condition of the test organisms. If the acclimation process is
1329
repeated with a new group of test organisms and excessive mortality
1330
occurs, it is recommended that an alternative source of dilution
1331
water be used.
1332
1333
1334
6.6.4
1335
The marine organisms can be used at all concentrations of
1336
effluent by adjusting the salinity of the effluent to salinities
1337
specified for the appropriate species test condition or to the
1338
salinity approximating that of the receiving water, by adding
1339
sufficient dry ocean salts, such as FORTY FATHOMS®, or equivalent,
1340
GP2, or hypersaline brine.
1341
1342
1343
6.6.5
1344
Saline dilution water can be prepared with deionized
1345
water or a freshwater such as well water or a suitable surface
1346
water. If dry ocean salts are used, care must be taken to ensure
1347
that the added salts are completely dissolved and the solution is
1348
aerated 24 h before the test organisms are placed in the solutions.
1349
The test organisms should be acclimated in synthetic saline water
1350
prepared with the dry salts. Caution: addition of dry ocean salts
1351
to dilution water may result in an increase in pH. (The pH of
1352
estuarine and coastal saline waters is normally
1353
7.5-8.3).
1354
1355
1356
6.6.6
1357
All effluent concentrations and the
1358
control(s) used in a test should have the same salinity. The change
1359
in salinity upon acclimation at the desired test dilution should
1360
not exceed 6‰. The required salinities for culturing and toxicity
1361
tests with estuarine and marine species are listed in the test
1362
method sections.
1363
1364
1365
6.7
1366
TEST ORGANISM DISPOSAL
1367
1368
1369
6.7.1 When the toxicity test(s) is concluded, all test organisms
1370
(including controls) should be humanely destroyed and disposed of
1371
in an appropriate manner.
1372
SECTION 7
1373
DILUTION WATER
1374
7.1 TYPES OF DILUTION WATER
1375
7.1.1 The type of dilution water used in effluent toxicity tests
1376
will depend largely on the objectives of the study.
1377
1378
1379
7.1.1.1
1380
If the objective of the test is to estimate the absolute
1381
chronic toxicity of the effluent, a synthetic (standard) dilution
1382
water is used. If the test organisms have been cultured in water
1383
which is different from the test dilution water, a second set of
1384
controls, using culture water, should be included in the
1385
test.
1386
1387
1388
7.1.1.2
1389
If the objective of the test is to estimate the chronic
1390
toxicity of the effluent in uncontaminated receiving water, the
1391
test may be conducted using dilution water consisting of a single
1392
grab sample of receiving water (if non-toxic), collected outside
1393
the influence of the outfall, or with other uncontaminated natural
1394
water (surface water) or standard dilution water having
1395
approximately the same salinity as the receiving water. Seasonal
1396
variations in the quality of receiving waters may affect effluent
1397
toxicity. Therefore, the salinity of saline receiving water samples
1398
should be determined before each use. If the test organisms have
1399
been cultured in water which is different from the test dilution
1400
water, a second set of controls, using culture water, should be
1401
included in the test.
1402
1403
1404
7.1.1.3
1405
If the objective of the test is to determine the additive
1406
or mitigating effects of the discharge on already contaminated
1407
receiving water, the test is performed using dilution water
1408
consisting of receiving water collected outside the influence of
1409
the outfall. A second set of controls, using culture water, should
1410
be included in the test.
1411
1412
1413
7.1.2
1414
An acceptable dilution water is one which is appropriate
1415
for the objectives of the test; supports adequate performance of
1416
the test organisms with respect to survival, growth, reproduction,
1417
or other responses that may be measured in the test (i.e.,
1418
consistently meets test acceptability criteria for control
1419
responses); is consistent in quality; and does not contain
1420
contaminants that could produce toxicity. Receiving waters,
1421
synthetic waters, or synthetic waters adjusted to approximate
1422
receiving water characteristics may be used for dilution provided
1423
that the water meets the above listed qualifications for an
1424
acceptable dilution water. USEPA (2000a) provides additional
1425
guidance on selecting appropriate dilution waters.
1426
1427
1428
7.1.3
1429
When dual controls (one control
1430
using culture water and one control using dilution water) are used
1431
(see Subsections 7.1.1.1 - 7.1.1.3 above), the dilution water
1432
control should be used to determine test acceptability. It is also
1433
the dilution water control that should be compared to effluent
1434
treatments in the calculation and reporting of test results. The
1435
culture water control should be used to evaluate the
1436
appropriateness of the dilution water source. Significant
1437
differences between organism responses in culture water and
1438
dilution water controls could indicate toxicity in the dilution
1439
water and may suggest an alternative dilution water source. USEPA
1440
(2000a) provides additional guidance on dual controls.
1441
1442
1443
7.2
1444
STANDARD, SYNTHETIC DILUTION WATER
1445
1446
1447
1448
1449
7.2.1
1450
Standard, synthetic, dilution water is prepared with
1451
deionized water and reagent grade chemicals (GP2) or commercial sea
1452
salts (FORTY FATHOMS®, HW MARINEMIX®) (Table 3). The source water
1453
for the deionizer can be ground water or tap water.
1454
1455
1456
7.2.2
1457
DEIONIZED WATER USED TO PREPARE STANDARD, SYNTHETIC,
1458
DILUTION WATER
1459
1460
1461
1462
1463
7.2.2.1
1464
Deionized water is obtained from a MILLIPORE MILLI-Q®,
1465
MILLIPORE® QPAK™2 or equivalent system. It is advisable to provide
1466
a preconditioned (deionized) feed water by using a Culligan®,
1467
Continental®, or equivalent system in front of the MILLI-Q® System
1468
to extend the life of the MILLI-Q® cartridges (see Section 5,
1469
Facilities, Equipment, and Supplies).
1470
1471
1472
7.2.2.2
1473
The recommended order of the cartridges in a
1474
four-cartridge deionizer (i.e., MILLI-Q® System or equivalent) is:
1475
(1) ion exchange, (2) ion exchange, (3) carbon, and (4) organic
1476
cleanup (such as ORGANEX-Q®, or equivalent), followed by a final
1477
bacteria filter. The QPAK™2 water system is a sealed system which
1478
does not allow for the rearranging of the cartridges. However, the
1479
final cartridge is an ORGANEX-Q® filter, followed by a final
1480
bacteria filter. Commercial laboratories using this system have not
1481
experienced any difficulty in using the water for culturing or
1482
testing. Reference to the MILLI-Q® systems throughout the remainder
1483
of the manual includes all MILLIPORE® or equivalent
1484
systems.
1485
1486
1487
7.2.3
1488
STANDARD, SYNTHETIC SEAWATER
1489
1490
1491
7.2.3.1 To prepare 20 L of a standard, synthetic, reconstituted
1492
seawater (modified GP2), using reagent grade chemicals (Table 3),
1493
with a salinity of 31‰, follow the instructions below. Other
1494
salinities can be prepared by making the appropriate dilutions.
1495
Larger or smaller volumes of modified GP2 can be prepared by using
1496
proportionately larger or smaller amounts of salts and dilution
1497
water.
1498
1499
1500
1.
1501
Place 20 L of MILLI-Q® or equivalent deionized water in a
1502
properly cleaned plastic carboy.
1503
1504
1505
2.
1506
Weigh reagent grade salts listed in Table 3 and add, one
1507
at a time, to the deionized water. Stir well after adding each
1508
salt.
1509
1510
1511
3.
1512
Aerate the final solution at a rate of 1 L/h for 24
1513
h.
1514
1515
1516
4.
1517
Check the pH and salinity.
1518
1519
1520
1521
1522
7.2.3.2
1523
Synthetic seawater can also be prepared by adding
1524
commercial sea salts, such as FORTY FATHOMS®, HW MARINEMIX®, or
1525
equivalent, to deionized water. For example, thirty-one parts per
1526
thousand (31‰) FORTY FATHOMS® can be prepared by dissolving 31 g of
1527
sea salts per liter of deionized water. The salinity of the
1528
resulting solutions should be checked with a
1529
refractometer.
1530
1531
1532
7.2.4
1533
Artificial seawater is to be used only if specified in
1534
the method. EMSL-Cincinnati has found FORTY FATHOMS® artificial sea
1535
salts suitable for maintaining and spawning the sheepshead minnow,
1536
Cyprinodon variegatus, and for its use in the sheepshead minnow
1537
larval survival and growth test, suitable for maintaining and
1538
spawning the inland silverside, Menidia beryllina, and for its use
1539
in the inland silverside larval survival and growth test, suitable
1540
for culturing and maintaining mysid shrimp, Mysidopsis bahia, and
1541
its use in the mysid shrimp survival, growth, and fecundity test,
1542
and suitable for maintaining sea urchins, Arbacia punctulata, and
1543
for its use in the sea urchin fertilization test. The USEPA Region
1544
6 Houston Laboratory has successfully used HW MARINEMIX® sea salts
1545
to maintain and spawn sheepshead minnows, and perform the larval
1546
survival and growth test and the embryo-larval survival and
1547
teratogenicity test. Also, HW MARINEMIX® sea salts has been used
1548
successfully to culture and maintain the mysid brood stock and
1549
perform the mysid survival, growth, fecundity test. An artificial
1550
seawater formulation, GP2 (Spotte et al., 1984), Table 3, has been
1551
used by the Environmental Research Laboratory-Narragansett, RI for
1552
all but the embryolarval survival and teratogenicity test. The
1553
suitability of GP2 as a medium for culturing organisms has not been
1554
determined.
1555
1556
1557
TABLE 3. PREPARATION OF GP2 ARTIFICIAL SEAWATER USING REAGENT
1558
GRADE CHEMICALS1,2,3
1559
1560
1
1561
Modified GP2 from Spotte et al. (1984).
1562
2
1563
The constituent salts and concentrations were taken from USEPA
1564
(2002a). The salinity is 30.89 g/L.
1565
3
1566
GP2 can be diluted with deionized (DI) water to the desired test
1567
salinity.
1568
7.3 USE OF RECEIVING WATER AS DILUTION WATER
1569
1570
1571
7.3.1
1572
If the objectives of the test require the use of
1573
uncontaminated receiving water as dilution water, and the receiving
1574
water is uncontaminated, it may be possible to collect a sample of
1575
the receiving water close to the outfall, but should be away from
1576
or beyond the influence of the effluent. However, if the receiving
1577
water is contaminated, it may be necessary to collect the sample in
1578
an area "remote" from the discharge site, matching as closely as
1579
possible the physical and chemical characteristics of the receiving
1580
water near the outfall.
1581
1582
1583
7.3.2
1584
The sample should be collected immediately prior to the
1585
test, but never more than 96 h before the test begins. Except where
1586
it is used within 24 h, or in the case where large volumes are
1587
required for flow through tests, the sample should be chilled to
1588
0-6°C during or immediately following collection, and maintained at
1589
that temperature prior to use in the test.
1590
1591
1592
7.3.3
1593
The investigator should collect uncontaminated water
1594
having a salinity as near as possible to the salinity of the
1595
receiving water at the discharge site. Water should be collected at
1596
slack high tide, or within one hour after high tide. If there is
1597
reason to suspect contamination of the water in the estuary, it is
1598
advisable to collect uncontaminated water from an adjacent estuary.
1599
At times it may be necessary to collect water at a location closer
1600
to the open sea, where the salinity is relatively high. In such
1601
cases, deionized water or uncontaminated freshwater is added to the
1602
saline water to dilute it to the required test salinity. Where
1603
necessary, the salinity of a surface water can be increased by the
1604
addition of artificial sea salts, such as FORTY FATHOMS®, HW
1605
MARINEMIX®, or equivalent, GP2, a
1606
1607
1608
natural seawater of higher salinity, or hypersaline brine.
1609
Instructions for the preparation of hypersaline brine by
1610
concentrating natural seawater are provided below.
1611
1612
1613
7.3.4
1614
Receiving water containing debris or indigenous
1615
organisms, that may be confused with or attack the test organisms,
1616
should be filtered through a sieve having 60 µm mesh openings prior
1617
to use.
1618
1619
1620
7.3.5
1621
HYPERSALINE BRINE
1622
1623
1624
1625
1626
7.3.5.1
1627
Hypersaline brine (HSB) has several advantages that make
1628
it desirable for use in toxicity testing. It can be made from any
1629
high quality, filtered seawater by evaporation, and can be added to
1630
deionized water to prepare dilution water, or to effluents or
1631
surface waters to increase their salinity.
1632
1633
1634
7.3.5.2
1635
The ideal container for making HSB from natural seawater
1636
is one that (l) has a high surface to volume ratio,
1637
1638
1639
(2) is made of a noncorrosive material, and (3) is easily
1640
cleaned (fiberglass containers are ideal). Special care should be
1641
used to prevent any toxic materials from coming in contact with the
1642
seawater being used to generate the brine. If a heater is immersed
1643
directly into the seawater, ensure that the heater materials do not
1644
corrode or leach any substances that would contaminate the brine.
1645
One successful method used is a thermostatically controlled heat
1646
exchanger made from fiberglass. If aeration is used, use only
1647
oil-free air compressors to prevent contamination.
1648
1649
1650
7.3.5.3
1651
Before adding seawater to the brine generator, thoroughly
1652
clean the generator, aeration supply tube, heater, and any other
1653
materials that will be in direct contact with the brine. A good
1654
quality biodegradable detergent should be used, followed by several
1655
thorough deionized water rinses. High quality (and preferably high
1656
salinity) seawater should be filtered to at least 10 mm before
1657
placing into the brine generator. Water should be collected on an
1658
incoming tide to minimize the possibility of
1659
contamination.
1660
1661
1662
7.3.5.4
1663
The temperature of the seawater is increased slowly to
1664
40°C. The water should be aerated to prevent temperature
1665
stratification and to increase water evaporation. The brine should
1666
be checked daily (depending on the volume being generated) to
1667
ensure that the salinity does not exceed 100‰ and that the
1668
temperature does not exceed 40°C. Additional seawater may be added
1669
to the brine to obtain the volume of brine required.
1670
1671
1672
7.3.5.5
1673
After the required salinity is attained, the HSB should
1674
be filtered a second time through a l-µm filter and poured directly
1675
into portable containers (20-L CUBITAINERS® or polycarbonate water
1676
cooler jugs are suitable). The containers should be capped and
1677
labelled with the date the brine was generated and its salinity.
1678
Containers of HSB should be stored in the dark and maintained under
1679
room temperature until used.
1680
1681
1682
7.3.5.6
1683
If a source of HSB is available, test solutions can be
1684
made by following the directions below. Thoroughly mix together the
1685
deionized water and brine before mixing in the effluent.
1686
1687
1688
7.3.5.7
1689
Divide the salinity of the HSB by the expected test
1690
salinity to determine the proportion of deionized water to brine.
1691
For example, if the salinity of the brine is 100‰ and the test is
1692
to be conducted at 25‰, 100‰ divided by 25‰ = 4.0. The proportion
1693
of brine is 1 part in 4 (one part brine to three parts deionized
1694
water).
1695
1696
1697
7.3.5.8
1698
To make 1 L of seawater at 25‰ salinity from a
1699
hypersaline brine of 100‰, 250 mL of brine and 750 mL of deionized
1700
water are required.
1701
1702
1703
7.4
1704
USE OF TAP WATER AS DILUTION WATER
1705
1706
1707
7.4.1 The use of tap water in the reconstituting of synthetic
1708
(artificial) seawater as dilution water is discouraged unless it is
1709
dechlorinated and fully treated. Tap water can be dechlorinated by
1710
deionization, carbon filtration, or the use of sodium thiosulfate.
1711
Use of 3.6 mg/L (anhydrous) sodium thiosulfate will reduce 1.0 mg
1712
chlorine/L (APHA, 1992). Following dechlorination, total residual
1713
chlorine should not exceed 0.01 mg/L. Because of the possible
1714
toxicity of thiosulfate to test organisms, a control lacking
1715
thiosulfate should be included in toxicity tests utilizing
1716
thiosulfate-dechlorinated water.
1717
1718
1719
7.4.2
1720
To be adequate for general laboratory use following
1721
dechlorination, the tap water is passed through a deionizer and
1722
carbon filter to remove toxic metals and organics, and to control
1723
hardness and alkalinity.
1724
1725
1726
7.5
1727
DILUTION WATER HOLDING
1728
1729
1730
7.5.1 A given batch of dilution water should not be used for
1731
more than 14 days following preparation because of the possible
1732
build up of bacterial, fungal, or algal slime growth and the
1733
problems associated with it. The container should be kept covered
1734
and the contents should be protected from light.
1735
SECTION 8
1736
EFFLUENT AND RECEIVING WATER SAMPLING, SAMPLE HANDLING, AND
1737
SAMPLE PREPARATION FOR TOXICITY TESTS
1738
8.1 EFFLUENT SAMPLING
1739
1740
1741
8.1.1
1742
The effluent sampling point should be the same as that
1743
specified in the NPDES discharge permit (USEPA, l988b). Conditions
1744
for exception would be: (l) better access to a sampling point
1745
between the final treatment and the discharge outfall; (2) if the
1746
processed waste is chlorinated prior to discharge, it may also be
1747
desirable to take samples prior to contact with the chlorine to
1748
determine toxicity of the unchlorinated effluent; or (3) in the
1749
event there is a desire to evaluate the toxicity of the influent to
1750
municipal waste treatment plants or separate wastewater streams in
1751
industrial facilities prior to their being combined with other
1752
wastewater streams or non-contact cooling water, additional
1753
sampling points may be chosen.
1754
1755
1756
8.1.2
1757
The decision on whether to collect grab or composite
1758
samples is based on the objectives of the test and an understanding
1759
of the short and long-term operations and schedules of the
1760
discharger. If the effluent quality varies considerably with time,
1761
which can occur where holding times are short, grab samples may
1762
seem preferable because of the ease of collection and the potential
1763
of observing peaks (spikes) in toxicity. However, the sampling
1764
duration of a grab sample is so short that full characterization of
1765
an effluent over a 24-h period would require a prohibitively large
1766
number of separate samples and tests. Collection of a 24-h
1767
composite sample, however, may dilute toxicity spikes, and average
1768
the quality of the effluent over the sampling period. Sampling
1769
recommendations are provided below (also see USEPA,
1770
2002a).
1771
1772
1773
8.1.3
1774
Aeration during collection and transfer of effluents
1775
should be minimized to reduce the loss of volatile
1776
chemicals.
1777
1778
1779
8.1.4
1780
Details of date, time, location, duration, and procedures
1781
used for effluent sample and dilution water collection should be
1782
recorded.
1783
1784
1785
8.2
1786
EFFLUENT SAMPLE TYPES
1787
1788
1789
8.2.1 The advantages and disadvantages of effluent grab and
1790
composite samples are listed below:
1791
8.2.1.1 GRAB SAMPLES Advantages:
1792
1793
1794
1.
1795
Easy to collect; require a minimum of equipment and
1796
on-site time.
1797
1798
1799
2.
1800
Provide a measure of instantaneous toxicity. Toxicity
1801
spikes are not masked by dilution. Disadvantages:
1802
1803
1804
1. Samples are collected over a very short period of time and on
1805
a relatively infrequent basis. The chances of detecting a spike in
1806
toxicity would depend on the frequency of sampling, and the
1807
probability of missing spikes is high.
1808
8.2.1.2 COMPOSITE SAMPLES: Advantages:
1809
1810
1811
1.
1812
A single effluent sample is collected over a 24-h
1813
period.
1814
1815
1816
2.
1817
The sample is collected over a much longer period of time
1818
than grab samples and contains all toxicity spikes.
1819
1820
1821
Disadvantages:
1822
1823
1824
1.
1825
Sampling equipment is more sophisticated and expensive,
1826
and must be placed on-site for at least 24 h.
1827
1828
1829
2.
1830
Toxicity spikes may not be detected because they are
1831
masked by dilution with less toxic wastes.
1832
1833
1834
8.3 EFFLUENT SAMPLING RECOMMENDATIONS
1835
1836
1837
8.3.1
1838
When tests are conducted on-site, test solutions can be
1839
renewed daily with freshly collected samples.
1840
1841
1842
8.3.2
1843
When tests are conducted off-site, a minimum of three
1844
samples are collected. If these samples are collected on Test Days
1845
1, 3, and 5, the first sample would be used for test initiation,
1846
and for test solution renewal on Day 2. The second sample would be
1847
used for test solution renewal on Days 3 and 4. The third sample
1848
would be used for test solution renewal on Days 5, 6, and
1849
7.
1850
1851
1852
8.3.3
1853
Sufficient sample must be collected to perform the
1854
required toxicity and chemical tests. A 4-L (1-gal) CUBITAINER®
1855
will provide sufficient sample volume for most tests.
1856
1857
1858
8.3.4
1859
THE FOLLOWING EFFLUENT SAMPLING METHODS ARE
1860
RECOMMENDED:
1861
1862
1863
8.3.4.1 Continuous Discharges
1864
1865
1866
8.3.4.1.1
1867
If the facility discharge is continuous, a single 24-h
1868
composite sample is to be taken.
1869
1870
1871
8.3.4.2
1872
Intermittent Discharges
1873
1874
1875
1876
1877
8.3.4.2.1
1878
If the facility discharge is intermittent, a composite
1879
sample is to be collected for the duration of the discharge but not
1880
more than 24 hours.
1881
1882
1883
8.4
1884
RECEIVING WATER SAMPLING
1885
1886
1887
1888
1889
8.4.1
1890
Logistical problems and difficulty in securing sampling
1891
equipment generally preclude the collection of composite receiving
1892
water samples for toxicity tests. Therefore, based on the
1893
requirements of the test, a single grab sample or daily grab
1894
samples of receiving water is collected for use in the
1895
test.
1896
1897
1898
8.4.2
1899
The sampling point is determined by the objectives of the
1900
test. At estuarine and marine sites, samples should be collected at
1901
mid-depth.
1902
1903
1904
8.4.3
1905
To determine the extent of the zone of toxicity in the
1906
receiving water at estuarine and marine effluent sites, receiving
1907
water samples are collected at several distances away from the
1908
discharge. The time required for the effluent-receiving-water
1909
mixture to travel to sampling points away from the effluent, and
1910
the rate and degree of mixing, may be difficult to ascertain.
1911
Therefore, it may not be possible to correlate receiving water
1912
toxicity with effluent toxicity at the discharge point unless a dye
1913
study is performed. The toxicity of receiving water samples from
1914
five stations in the discharge plume can be evaluated using the
1915
same number of test vessels and test organisms as used in one
1916
effluent toxicity test with five effluent dilutions.
1917
1918
1919
8.5
1920
EFFLUENT AND RECEIVING WATER SAMPLE HANDLING,
1921
PRESERVATION, AND SHIPPING
1922
1923
1924
1925
1926
8.5.1
1927
Unless the samples are used in an on-site toxicity test
1928
the day of collection (or hand delivered to the testing laboratory
1929
for use on the day of collection), it is recommended that they be
1930
held at 0-6°C until used to inhibit microbial degradation, chemical
1931
transformations, and loss of highly volatile toxic
1932
substances.
1933
1934
1935
8.5.2
1936
Composite samples should be chilled as they are
1937
collected. Grab samples should be chilled immediately following
1938
collection.
1939
1940
1941
8.5.3
1942
If the effluent has been chlorinated, total residual
1943
chlorine must be measured immediately following sample
1944
collection.
1945
1946
1947
8.5.4
1948
Sample holding time begins when the last grab sample in a
1949
series is taken (i.e., when a series of four grab samples are taken
1950
over a 24-h period), or when a 24-h composite sampling period is
1951
completed. If the data from the samples are to be acceptable for
1952
use in the NPDES Program, the lapsed time (holding time) from
1953
sample collection to first use of each grab or composite sample
1954
must not exceed 36 h. EPA believes that 36 h is adequate time to
1955
deliver the sample to the laboratories performing the test in most
1956
cases. In the isolated cases, where the permittee can document that
1957
this delivery time cannot be met, the permitting authority can
1958
allow an option for on-site testing or a variance for an extension
1959
of shipped sample holding time. The request for a variance in
1960
sample holding time, directed to the USEPA Regional Administrator
1961
under 40 CFR 136.3(e), should include supportive data which show
1962
that the toxicity of the effluent sample is not reduced (e.g.,
1963
because of volatilization and/or sorption of toxics on the sample
1964
container surfaces) by extending the holding time beyond more than
1965
36 h. However, in no case should more than 72 h elapse between
1966
collection and first use of the sample. In static-renewal tests,
1967
each grab or composite sample may also be used to prepare test
1968
solutions for renewal at 24 h and/or 48 h after first use, if
1969
stored at 0-6°C, with minimum head space, as described in
1970
Subsection 8.5. If shipping problems (e.g., unsuccessful Saturday
1971
delivery) are encountered with renewal samples after a test has
1972
been initiated, the permitting authority may allow the continued
1973
use of the most recently used sample for test renewal. Guidance for
1974
determining the persistence of the sample is provided in Subsection
1975
8.7.
1976
1977
1978
8.5.5
1979
To minimize the loss of toxicity due to volatilization of
1980
toxic constituents, all sample containers should be "completely"
1981
filled, leaving no air space between the contents and the
1982
lid.
1983
1984
1985
8.5.6
1986
SAMPLES USED IN ON-SITE TESTS
1987
1988
1989
1990
1991
8.5.6.1
1992
Samples collected for on-site tests should be used within
1993
24 h.
1994
1995
1996
8.5.7
1997
SAMPLES SHIPPED TO OFF SITE FACILITIES
1998
1999
2000
2001
2002
8.5.7.1
2003
Samples collected for off site toxicity testing are to be
2004
chilled to 0-6°C during or immediately after collection, and
2005
shipped iced to the performing laboratory. Sufficient ice should be
2006
placed with the sample in the shipping container to ensure that ice
2007
will still be present when the sample arrives at the laboratory and
2008
is unpacked. Insulating material should not be placed between the
2009
ice and the sample in the shipping container unless required to
2010
prevent breakage of glass sample containers.
2011
2012
2013
8.5.7.2
2014
Samples may be shipped in one or more 4-L (l-gal)
2015
CUBITAINERS® or new plastic "milk" jugs. All sample containers
2016
should be rinsed with source water before being filled with sample.
2017
After use with receiving water or effluents, CUBITAINERS® and
2018
plastic jugs are punctured to prevent reuse.
2019
2020
2021
8.5.7.3
2022
Several sample shipping options are available, including
2023
Express Mail, air express, bus, and courier service. Express Mail
2024
is delivered seven days a week. Saturday and Sunday shipping and
2025
receiving schedules of private carriers vary with the
2026
carrier.
2027
2028
2029
8.6
2030
SAMPLE RECEIVING
2031
2032
2033
2034
2035
8.6.1
2036
Upon arrival at the laboratory, samples are logged in and
2037
the temperature is measured and recorded. If the samples are not
2038
immediately prepared for testing, they are stored at 0-6°C until
2039
used.
2040
2041
2042
8.6.2
2043
Every effort must be made to initiate the test with an
2044
effluent sample on the day of arrival in the laboratory, and the
2045
sample holding time should not exceed 36 h unless a variance has
2046
been granted by the NPDES permitting authority.
2047
2048
2049
8.7
2050
PERSISTENCE OF EFFLUENT TOXICITY DURING SAMPLE SHIPMENT
2051
AND HOLDING
2052
2053
2054
2055
2056
8.7.1
2057
The persistence of the toxicity of
2058
an effluent prior to its use in a toxicity test is of interest in
2059
assessing the validity of toxicity test data, and in determining
2060
the possible effects of allowing an extension of the holding time.
2061
Where a variance in holding time (> 36 h, but # 72 h) is
2062
requested by a permittee (See Subsection 8.5.4), information on the
2063
effects of the extension in holding time on the toxicity of the
2064
samples must be obtained by comparing the results of
2065
multi-concentration chronic toxicity tests performed on effluent
2066
samples held 36 h with toxicity test results using the same samples
2067
after they were held for the requested, longer period. The portion
2068
of the sample set aside for the second test must be held under the
2069
same conditions as during shipment and holding.
2070
2071
2072
8.8
2073
PREPARATION OF EFFLUENT AND RECEIVING WATER SAMPLES FOR
2074
TOXICITY TESTS
2075
2076
2077
2078
2079
8.8.1
2080
Adjust the sample salinity to the level appropriate for
2081
objectives of the study using hypersaline brine or artificial sea
2082
salts.
2083
2084
2085
8.8.2
2086
When aliquots are removed from the sample container, the
2087
head space above the remaining sample should be held to a minimum.
2088
Air which enters a container upon removal of sample should be
2089
expelled by compressing the container before reclosing, if possible
2090
(i.e., where a CUBITAINER® used), or by using an appropriate
2091
discharge valve (spigot).
2092
2093
2094
8.8.3
2095
It may be necessary to first coarse-filter samples
2096
through a NYLON® sieve having 2 to 4 mm mesh openings to remove
2097
debris and/or break up large floating or suspended solids. If
2098
samples contain indigenous organisms that may attack or be confused
2099
with the test organisms, the samples should be filtered through a
2100
sieve with 60-µm mesh openings. Since filtering may increase the
2101
dissolved oxygen (DO) in an effluent, the DO should be checked both
2102
before and after filtering. Low dissolved oxygen concentrations
2103
will indicate a potential problem in performing the test. Caution:
2104
filtration may remove some toxicity.
2105
2106
2107
8.8.4
2108
If the samples must be warmed to bring them to the
2109
prescribed test temperature, supersaturation of the dissolved
2110
oxygen and nitrogen may become a problem. To avoid this problem,
2111
samples may be warmed slowly in open test containers. If DO is
2112
still above 100% saturation, based on temperature and salinity
2113
(Table 4), after warming to test temperature, samples should be
2114
aerated moderately (approximately 500 mL/min) for a few minutes
2115
using an airstone. If DO is below 4.0 mg/L, the solutions must be
2116
aerated moderately (approximately 500 mL/min) for a few minutes,
2117
using an airstone, until the DO is within the prescribed range ($
2118
4.0 mg/L). Caution: avoid excessive aeration.
2119
2120
2121
2122
2123
8.8.4.1
2124
Aeration during the test may alter the results and should
2125
be used only as a last resort to maintain the required DO. Aeration
2126
can reduce the apparent toxicity of the test solutions by stripping
2127
them of highly volatile toxic substances, or increase their
2128
toxicity by altering the pH. However, the DO in the test solution
2129
should not be permitted to fall below 4.0 mg/L.
2130
2131
2132
8.8.4.2
2133
In static tests (non-renewal or renewal) low DOs may
2134
commonly occur in the higher concentrations of wastewater. Aeration
2135
is accomplished by bubbling air through a pipet at the rate of 100
2136
bubbles/min. If aeration is necessary, all test solutions must be
2137
aerated. It is advisable to monitor the DO closely during the first
2138
few hours of the test. Samples with a potential DO problem
2139
generally show a downward trend in DO within 4 to 8 h after the
2140
test
2141
2142
2143
is started. Unless aeration is initiated during the first 8 h of
2144
the test, the DO may be exhausted during an unattended period,
2145
thereby invalidating the test.
2146
8.8.5 At a minimum, pH, conductivity or salinity, and total
2147
residual chlorine are measured in the undiluted effluent or
2148
receiving water, and pH and conductivity are measured in the
2149
dilution water.
2150
2151
2152
8.8.5.1
2153
It is recommended that total alkalinity and total
2154
hardness also be measured in the undiluted effluent test water and
2155
the dilution water.
2156
2157
2158
8.8.6
2159
Total ammonia is measured in effluent and receiving water
2160
samples where toxicity may be contributed by unionized ammonia
2161
(i.e., where total ammonia $ 5 mg/L). The concentration (mg/L) of
2162
unionized (free) ammonia in a sample is a function of temperature
2163
and pH, and is calculated using the percentage value obtained from
2164
Table 5, under the appropriate pH and temperature, and multiplying
2165
it by the concentration (mg/L) of total ammonia in the
2166
sample.
2167
2168
2169
8.8.7
2170
Effluents and receiving waters can be dechlorinated using
2171
6.7 mg/L anhydrous sodium thiosulfate to reduce 1 mg/L chlorine
2172
(APHA, 1992). Note that the amount of thiosulfate required to
2173
dechlorinate effluents is greater than the amount needed to
2174
dechlorinate tap water, (see Section 7, Dilution Water). Since
2175
thiosulfate may contribute to sample toxicity, a thiosulfate
2176
control should be used in the test in addition to the normal
2177
dilution water control.
2178
2179
2180
8.8.8
2181
The DO concentration in the samples should be near
2182
saturation prior to use. Aeration will bring the DO and other gases
2183
into equilibrium with air, minimize oxygen demand, and stabilize
2184
the pH. However, aeration during collection, transfer, and
2185
preparation of samples should be minimized to reduce the loss of
2186
volatile chemicals.
2187
2188
2189
8.8.9
2190
Mortality or impairment of growth or reproduction due to
2191
pH alone may occur if the pH of the sample falls outside the range
2192
of 6.0 - 9.0. Thus, the presence of other forms of toxicity (metals
2193
and organics) in the sample may be masked by the toxic effects of
2194
low or high pH. The question about the presence of other toxicants
2195
can be answered only by performing two parallel tests, one with an
2196
adjusted pH, and one without an adjusted pH. Freshwater samples are
2197
adjusted to pH 7.0, and marine samples are adjusted to pH 8.0, by
2198
adding 1N NaOH or 1N HCl dropwise, as required, being careful to
2199
avoid overadjustment.
2200
2201
2202
2203
2204
2205
Table provided by Teresa Norberg-King, Duluth, Minnesota. Also
2206
see Emerson et al. (1975), Thurston et al. (1974), and USEPA
2207
(1985a).
2208
8.9 PRELIMINARY TOXICITY RANGE-FINDING
2209
TESTS
2210
2211
2212
8.9.1
2213
USEPA Regional and State personnel generally have
2214
observed that it is not necessary to conduct a toxicity
2215
range-finding test prior to initiating a static, chronic,
2216
definitive toxicity test. However, when preparing to perform a
2217
static test with a sample of completely unknown quality, or before
2218
initiating a flow-through test, it is advisable to conduct a
2219
preliminary toxicity range-finding test.
2220
2221
2222
8.9.2
2223
A toxicity range-finding test ordinarily consists of a
2224
down-scaled, abbreviated static acute test in which groups of five
2225
organisms are exposed to several widely-spaced sample dilutions in
2226
a logarithmic series, such as 100%, 10.0%, 1.00%, and 0.100%, and a
2227
control, for 8-24 h. Caution: if the sample must also be used for
2228
the fullscale definitive test, the 36-h limit on holding time (see
2229
Subsection 8.5.4) must not be exceeded before the definitive test
2230
is initiated.
2231
2232
2233
8.9.3
2234
It should be noted that the toxicity (LC50) of a sample
2235
observed in a range-finding test may be significantly different
2236
from the toxicity observed in the follow-up, chronic, definitive
2237
test because: (1) the definitive test is longer; and (2) the test
2238
may be performed with a sample collected at a different time, and
2239
possibly differing significantly in the level of
2240
toxicity.
2241
2242
2243
8.10 MULTICONCENTRATION (DEFINITIVE)
2244
EFFLUENT TOXICITY TESTS
2245
2246
2247
8.10.1
2248
The tests recommended for use in determining discharge
2249
permit compliance in the NPDES program are multiconcentration, or
2250
definitive, tests which provide (1) a point estimate of effluent
2251
toxicity in terms of an IC25, IC50, or LC50, or (2) a
2252
no-observed-effect-concentration (NOEC) defined in terms of
2253
mortality, growth, reproduction, and/or teratogenicity and obtained
2254
by hypothesis testing. The tests may be static renewal or static
2255
non-renewal.
2256
2257
2258
8.10.2
2259
The tests consist of a control and a minimum of five
2260
effluent concentrations. USEPA recommends the use of a $0.5
2261
dilution factor for selecting effluent test concentrations.
2262
Effluent test concentrations of 6.25%, 12.5%, 25%, 50%, and 100%
2263
are commonly used, however, test concentrations should be selected
2264
independently for each test based on the objective of the study,
2265
the expected range of toxicity, the receiving water concentration,
2266
and any available historical testing information on the effluent.
2267
USEPA (2000a) provides additional guidance on choosing appropriate
2268
test concentrations.
2269
2270
2271
8.10.3
2272
When these tests are used in
2273
determining compliance with permit limits, effluent test
2274
concentrations should be selected to bracket the receiving water
2275
concentration. This may be achieved by selecting effluent test
2276
concentrations in the following manner: (1) 100% effluent, (2) [RWC
2277
+ 100]/2, (3) RWC, (4) RWC/2, and (5) RWC/4. For example, where the
2278
RWC = 50%, appropriate effluent concentrations may be 100%, 75%,
2279
50%, 25%, and 12.5%.
2280
2281
2282
8.10.4
2283
If acute/chronic ratios are to be determined by
2284
simultaneous acute and short-term chronic tests with a single
2285
species, using the same sample, both types of tests must use the
2286
same test conditions, i.e., pH, temperature, water hardness,
2287
salinity, etc.
2288
2289
2290
8.11
2291
RECEIVING WATER TESTS
2292
2293
2294
2295
2296
8.11.1
2297
Receiving water toxicity tests generally consist of 100%
2298
receiving water and a control. The total salinity of the control
2299
should be comparable to the receiving water.
2300
2301
2302
8.11.2
2303
The data from the two treatments are analyzed by
2304
hypothesis testing to determine if test organism survival in the
2305
receiving water differs significantly from the control. Four
2306
replicates and 10 organisms per replicate are required for each
2307
treatment (see Summary of Test Conditions and Test Acceptability
2308
Criteria in the specific test method).
2309
2310
2311
8.11.3
2312
In cases where the objective of the test is to estimate
2313
the degree of toxicity of the receiving water, a definitive,
2314
multiconcentration test is performed by preparing dilutions of the
2315
receiving water, using a $0.5 dilution series, with a suitable
2316
control water.
2317
2318
2319
SECTION 9
2320
CHRONIC TOXICITY TEST ENDPOINTS AND DATA
2321
ANALYSIS
2322
9.1 ENDPOINTS
2323
9.1.1 The objective of chronic aquatic toxicity tests with
2324
effluents and pure compounds is to estimate the highest "safe" or
2325
"no-effect concentration" of these substances. For practical
2326
reasons, the responses observed in these tests are usually limited
2327
to hatchability, gross morphological abnormalities, survival,
2328
growth, and reproduction, and the results of the tests are usually
2329
expressed in terms of the highest toxicant concentration that has
2330
no statistically significant observed effect on these responses,
2331
when compared to the controls. The terms currently used to define
2332
the endpoints employed in the rapid, chronic and sub-chronic
2333
toxicity tests have been derived from the terms previously used for
2334
full life-cycle tests. As shorter chronic tests were developed, it
2335
became common practice to apply the same terminology to the
2336
endpoints. The terms used in this manual are as follows:
2337
2338
2339
9.1.1.1
2340
Safe Concentration - The highest concentration of
2341
toxicant that will permit normal propagation of fish and other
2342
aquatic life in receiving waters. The concept of a "safe
2343
concentration" is a biological concept, whereas the
2344
"no-observed-effect concentration" (below) is a statistically
2345
defined concentration.
2346
2347
2348
9.1.1.2
2349
No-Observed-Effect-Concentration (NOEC) - The highest
2350
concentration of toxicant to which organisms are exposed in a full
2351
life-cycle or partial life-cycle (short-term) test, that causes no
2352
observable adverse effects on the test organisms (i.e., the highest
2353
concentration of toxicant in which the values for the observed
2354
responses are not statistically significantly different from the
2355
controls). This value is used, along with other factors, to
2356
determine toxicity limits in permits.
2357
2358
2359
9.1.1.3
2360
Lowest-Observed-Effect-Concentration (LOEC) - The lowest
2361
concentration of toxicant to which organisms are exposed in a
2362
life-cycle or partial life-cycle (short-term) test, which causes
2363
adverse effects on the test organisms (i.e., where the values for
2364
the observed responses are statistically significantly different
2365
from the controls).
2366
2367
2368
9.1.1.4
2369
Effective Concentration (EC) - A point estimate of the
2370
toxicant concentration that would cause an observable adverse
2371
affect on a quantal, "all or nothing," response (such as death,
2372
immobilization, or serious incapacitation) in a given percent of
2373
the test organisms, calculated by point estimation techniques. If
2374
the observable effect is death or immobility, the term, Lethal
2375
Concentration (LC), should be used (see Subsection 9.1.1.5). A
2376
certain EC or LC value might be judged from a biological standpoint
2377
to represent a threshold concentration, or lowest concentration
2378
that would cause an adverse effect on the observed
2379
response.
2380
2381
2382
9.1.1.5
2383
Lethal Concentration (LC) - The
2384
toxicant concentration that would cause death in a given percent of
2385
the test population. Identical to EC when the observable adverse
2386
effect is death. For example, the LC50 is the concentration of
2387
toxicant that would cause death in 50% of the test
2388
population.
2389
2390
2391
9.1.1.6
2392
Inhibition Concentration (IC) - The toxicant
2393
concentration that would cause a given percent reduction in a
2394
nonquantal biological measurement for the test population. For
2395
example, the IC25 is the concentration of toxicant that would cause
2396
a 25% reduction in mean young per female or in growth for the test
2397
population, and the IC50 is the concentration of toxicant that
2398
would cause a 50% reduction in the mean population
2399
responses.
2400
2401
2402
9.2
2403
RELATIONSHIP BETWEEN ENDPOINTS DETERMINED BY HYPOTHESIS
2404
TESTING AND POINT ESTIMATION TECHNIQUES
2405
2406
2407
9.2.1 If the objective of chronic aquatic toxicity tests with
2408
effluents and pure compounds is to estimate the highest "safe or
2409
no-effect concentration" of these substances, it is imperative to
2410
understand how the statistical endpoints of these tests are related
2411
to the "safe" or "no-effect" concentration. NOECs and LOECs are
2412
determined by hypothesis testing (Dunnett's Test, a t test with the
2413
Bonferroni adjustment, Steel's Many-One Rank Test, or the Wilcoxon
2414
Rank Sum Test with Bonferroni adjustment), whereas LCs, ICs, and
2415
ECs are determined by point estimation techniques (Probit Analysis,
2416
the Spearman-Karber Method, the Trimmed Spearman-Karber Method, the
2417
Graphical Method or Linear Interpolation Method). There are
2418
inherent differences between the use of a NOEC or LOEC derived from
2419
hypothesis testing to estimate a "safe" concentration, and the use
2420
of a LC, IC, EC, or other point estimates derived from curve
2421
fitting, interpolation, etc.
2422
2423
2424
9.2.2
2425
Most point estimates, such as the LC, IC, or EC are
2426
derived from a mathematical model that assumes a continuous
2427
dose-response relationship. By definition, any LC, IC, or EC value
2428
is an estimate of some amount of adverse effect. Thus the
2429
assessment of a "safe" concentration must be made from a biological
2430
standpoint rather than with a statistical test. In this instance,
2431
the biologist must determine some amount of adverse effect that is
2432
deemed to be "safe," in the sense that from a practical biological
2433
viewpoint it will not affect the normal propagation of fish and
2434
other aquatic life in receiving waters.
2435
2436
2437
9.2.3
2438
The use of NOECs and LOECs, on the other hand, assumes
2439
either (1) a continuous dose-response relationship, or (2) a
2440
non-continuous (threshold) model of the dose-response
2441
relationship.
2442
2443
2444
2445
2446
9.2.3.1
2447
In the case of a continuous dose-response relationship,
2448
it is also assumed that adverse effects that are not "statistically
2449
observable" are also not important from a biological standpoint,
2450
since they are not pronounced enough to test as statistically
2451
significant against some measure of the natural variability of the
2452
responses.
2453
2454
2455
9.2.3.2
2456
In the case of non-continuous dose-response
2457
relationships, it is assumed that there exists a true threshold, or
2458
concentration below which there is no adverse effect on aquatic
2459
life, and above which there is an adverse effect. The purpose of
2460
the statistical analysis in this case is to estimate as closely as
2461
possible where that threshold lies.
2462
2463
2464
9.2.3.3
2465
In either case, it is important to realize that the
2466
amount of adverse effect that is statistically observable (LOEC) or
2467
not observable (NOEC) is highly dependent on all aspects of the
2468
experimental design, such as the number of concentrations of
2469
toxicant, number of replicates per concentration, number of
2470
organisms per replicate, and use of randomization. Other factors
2471
that affect the sensitivity of the test include the choice of
2472
statistical analysis, the choice of an alpha level, and the amount
2473
of variability between responses at a given
2474
concentration.
2475
2476
2477
9.2.3.4
2478
Where the assumption of a continuous dose-response
2479
relationship is made, by definition some amount of adverse effect
2480
might be present at the NOEC, but is not great enough to be
2481
detected by hypothesis testing.
2482
2483
2484
9.2.3.5
2485
Where the assumption of a noncontinuous dose-response
2486
relationship is made, the NOEC would indeed be an estimate of a
2487
"safe" or "no-effect" concentration if the amount of adverse effect
2488
that appears at the threshold is great enough to test as
2489
statistically significantly different from the controls in the face
2490
of all aspects of the experimental design mentioned above. If,
2491
however, the amount of adverse effect at the threshold were not
2492
great enough to test as statistically different, some amount of
2493
adverse effect might be present at the NOEC. In any case, the
2494
estimate of the NOEC with hypothesis testing is always dependent on
2495
the aspects of the experimental design mentioned above. For this
2496
reason, the reporting and examination of some measure of the
2497
sensitivity of the test (either the minimum significant difference
2498
or the percent change from the control that this minimum difference
2499
represents) is extremely important.
2500
2501
2502
9.2.4
2503
In summary, the assessment of a "safe" or "no-effect"
2504
concentration cannot be made from the results of statistical
2505
analysis alone, unless (1) the assumptions of a strict threshold
2506
model are accepted, and (2) it is assumed that the amount of
2507
adverse effect present at the threshold is statistically detectable
2508
by hypothesis testing. In this case, estimates obtained from a
2509
statistical analysis are indeed estimates of a "no-effect"
2510
concentration. If the assumptions are not deemed tenable, then
2511
estimates from a statistical analysis can only be used in
2512
conjunction with an assessment from a biological standpoint of what
2513
magnitude of adverse effect constitutes a "safe" concentration. In
2514
this instance, a "safe" concentration is not necessarily a truly
2515
"no-effect" concentration, but rather a concentration at which the
2516
effects are judged to be of no biological significance.
2517
2518
2519
9.2.5
2520
A better understanding of the relationship between
2521
endpoints derived by hypothesis testing (NOECs) and point
2522
estimation techniques (LCs, ICs, and ECs) would be very helpful in
2523
choosing methods of data analysis. Norberg-King (1991) reported
2524
that the IC25s were comparable to the NOECs for 23 effluent and
2525
reference toxicant data sets analyzed. The data sets included
2526
short-term chronic toxicity tests for the sea urchin, Arbacia
2527
punctulata, the sheepshead minnow, Cyprinodon variegatus, and the
2528
red macroalga, Champia parvula. Birge et al. (1985) reported that
2529
LC1s derived from Probit Analyses of data from short-term
2530
embryo-larval tests with reference toxicants were comparable to
2531
NOECs for several organisms. Similarly, USEPA (1988d) reported that
2532
the IC25s were comparable to the NOECs for a set of daphnia,
2533
Ceriodaphnia dubia chronic tests with a single reference toxicant.
2534
However, the scope of these comparisons was very limited, and
2535
sufficient information is not yet available to establish an overall
2536
relationship between these two types of endpoints, especially when
2537
derived from effluent toxicity test data.
2538
2539
2540
9.3
2541
PRECISION
2542
2543
2544
9.3.1 HYPOTHESIS TESTS
2545
9.3.1.1 When hypothesis tests are used to analyze toxicity test
2546
data, it is not possible to express precision in terms of a
2547
commonly used statistic. The results of the test are given in terms
2548
of two endpoints, the No-Observed-Effect Concentration (NOEC) and
2549
the Lowest-Observed-Effect Concentration (LOEC). The NOEC and LOEC
2550
are limited to the concentrations selected for the test. The width
2551
of the NOEC-LOEC interval is a function of the dilution series, and
2552
differs greatly depending on whether a dilution factor of 0.3 or
2553
0.5 is used in the test design. Therefore, USEPA recommends the use
2554
of the $ 0.5 dilution factor (see Section 4, Quality Assurance). It
2555
is not possible to place confidence limits on the NOEC and LOEC
2556
derived from a given test, and it is difficult to quantify the
2557
precision of the NOEC-LOEC endpoints between tests. If the data
2558
from a series of tests performed with the same toxicant, toxicant
2559
concentrations, and test species, were analyzed with hypothesis
2560
tests, precision could only be assessed by a qualitative comparison
2561
of the NOEC-LOEC intervals, with the understanding that maximum
2562
precision would be attained if all tests yielded the same NOEC-LOEC
2563
interval. In practice, the precision of results of repetitive
2564
chronic tests is considered acceptable if the NOECs vary by no more
2565
than one concentration interval above or below a central tendency.
2566
Using these guidelines, the "normal" range of NOECs from toxicity
2567
tests using a
2568
0.5 dilution factor (two-fold difference between adjacent
2569
concentrations), would be four-fold.
2570
9.3.2 POINT ESTIMATION TECHNIQUES
2571
2572
2573
9.3.2.1
2574
Point estimation techniques have the advantage of
2575
providing a point estimate of the toxicant concentration causing a
2576
given amount of adverse (inhibiting) effect, the precision of which
2577
can be quantitatively assessed (1) within tests by calculation of
2578
95% confidence limits, and (2) across tests by calculating a
2579
standard deviation and coefficient of variation.
2580
2581
2582
9.3.2.2
2583
It should be noted that software
2584
used to calculate point estimates occasionally may not provide
2585
associated 95% confidence intervals. This situation may arise when
2586
test data do not meet specific assumptions required by the
2587
statistical methods, when point estimates are outside of the test
2588
concentration range, and when specific limitations imposed by the
2589
software are encountered. USEPA (2000a) provides guidance on
2590
confidence intervals under these circumstances.
2591
2592
2593
9.4
2594
DATA ANALYSIS
2595
2596
2597
9.4.1 ROLE OF THE STATISTICIAN
2598
9.4.1.1 The use of the statistical methods described in this
2599
manual for routine data analysis does not require the assistance of
2600
a statistician. However, the interpretation of the results of the
2601
analysis of the data from any of the toxicity tests described in
2602
this manual can become problematic because of the inherent
2603
variability and sometimes unavoidable anomalies in biological data.
2604
If the data appear unusual in any way, or fail to meet the
2605
necessary assumptions, a statistician should be consulted. Analysts
2606
who are not proficient in statistics are strongly advised to seek
2607
the assistance of a statistician before selecting the method of
2608
analysis and using any of the results.
2609
2610
2611
9.4.1.2
2612
The statistical methods recommended in this manual are
2613
not the only possible methods of statistical analysis. Many other
2614
methods have been proposed and considered. Certainly there are
2615
other reasonable and defensible methods of statistical analysis for
2616
this kind of toxicity data. Among alternative hypothesis tests
2617
some, like Williams' Test, require additional assumptions, while
2618
others, like the bootstrap methods, require computerintensive
2619
computations. Alternative point estimations approaches most
2620
probably would require the services of a statistician to determine
2621
the appropriateness of the model (goodness of fit), higher order
2622
linear or nonlinear models, confidence intervals for estimates
2623
generated by inverse regression, etc. In addition, point estimation
2624
or regression approaches would require the specification by
2625
biologists or toxicologists of some low level of adverse effect
2626
that would be deemed acceptable or safe. The statistical methods
2627
contained in this manual have been chosen because they are (1)
2628
applicable to most of the different toxicity test data sets for
2629
which they are recommended, (2) powerful statistical tests, (3)
2630
hopefully "easily" understood by nonstatisticians, and (4) amenable
2631
to use without a computer, if necessary.
2632
2633
2634
9.4.2
2635
PLOTTING THE DATA
2636
2637
2638
2639
2640
9.4.2.1
2641
The data should be plotted, both as a preliminary step to
2642
help detect problems and unsuspected trends or patterns in the
2643
responses, and as an aid in interpretation of the results. Further
2644
discussion and plotted sets of data are included in the methods and
2645
the Appendices.
2646
2647
2648
9.4.3
2649
DATA TRANSFORMATIONS
2650
2651
2652
2653
2654
9.4.3.1
2655
Transformations of the data, (e.g., arc sine square root
2656
and logs), are used where necessary to meet assumptions of the
2657
proposed analyses, such as the requirement for normally distributed
2658
data.
2659
2660
2661
9.4.4
2662
INDEPENDENCE, RANDOMIZATION, AND OUTLIERS
2663
2664
2665
2666
2667
9.4.4.1
2668
Statistical independence among observations is a critical
2669
assumption in all statistical analysis of toxicity data. One of the
2670
best ways to ensure independence is to properly follow rigorous
2671
randomization procedures. Randomization techniques should be
2672
employed at the start of the test, including the randomization of
2673
the placement of test organisms in the test chambers and
2674
randomization of the test chamber location within the array of
2675
chambers. Discussions of statistical independence, outliers and
2676
randomization, and a sample randomization scheme, are included in
2677
Appendix A.
2678
2679
2680
9.4.5
2681
REPLICATION AND SENSITIVITY
2682
2683
2684
2685
2686
9.4.5.1
2687
The number of replicates employed for each toxicant
2688
concentration is an important factor in determining the sensitivity
2689
of chronic toxicity tests. Test sensitivity generally increases as
2690
the number of replicates is increased, but the point of diminishing
2691
returns in sensitivity may be reached rather quickly. The level of
2692
sensitivity required by a hypothesis test or the confidence
2693
interval for a point estimate will determine the number of
2694
replicates, and should be based on the objectives for obtaining the
2695
toxicity data.
2696
2697
2698
9.4.5.2
2699
In a statistical analysis of toxicity data, the choice of
2700
a particular analysis and the ability to detect departures from the
2701
assumptions of the analysis, such as the normal distribution of the
2702
data and homogeneity of variance, is also dependent on the number
2703
of replicates. More than the minimum number of replicates may be
2704
required in situations where it is imperative to obtain optimal
2705
statistical results, such as with tests used in enforcement cases
2706
or when it is not possible to repeat the tests. For example, when
2707
the data are analyzed by hypothesis testing, the nonparametric
2708
alternatives cannot be used unless there are at least four
2709
replicates at each toxicant concentration.
2710
2711
2712
9.4.6
2713
RECOMMENDED ALPHA LEVELS
2714
2715
2716
2717
2718
9.4.6.1
2719
The data analysis examples included in the manual specify
2720
an alpha level of 0.01 for testing the assumptions of hypothesis
2721
tests and an alpha level of 0.05 for the hypothesis tests
2722
themselves. These levels are common and well accepted levels for
2723
this type of analysis and are presented as a recommended minimum
2724
significance level for toxicity data analysis.
2725
2726
2727
9.5
2728
CHOICE OF ANALYSIS
2729
2730
2731
2732
2733
9.5.1
2734
The recommended statistical analysis of most data from
2735
chronic toxicity tests with aquatic organisms follows a decision
2736
process illustrated in the flowchart in Figure 2. An initial
2737
decision is made to use point estimation techniques (the Probit
2738
Analysis, the Spearman-Karber Method, the Trimmed Spearman-Karber
2739
Method, the Graphical Method, or Linear Interpolation Method)
2740
and/or to use hypothesis testing (Dunnett's Test, the t test with
2741
the Bonferroni adjustment, Steel's Many-one Rank Test, or Wilcoxon
2742
Rank Sum Test with the Bonferroni adjustment). NOTE: For the NPDES
2743
Permit Program, the point estimation techniques are the preferred
2744
statistical methods in calculating end points for effluent toxicity
2745
tests. If hypothesis testing is chosen, subsequent decisions are
2746
made on the appropriate procedure for a given set of data,
2747
depending on the results of tests of assumptions, as illustrated in
2748
the flowchart. A specific flow chart is included in the analysis
2749
section for each test.
2750
2751
2752
9.5.2
2753
Since a single chronic toxicity test might yield
2754
information on more than one parameter (such as survival, growth,
2755
and reproduction), the lowest estimate of a "no-observed-effect
2756
concentration" for any of the responses would be used as the "no
2757
observed effect concentration" for each test. It follows logically
2758
that in the statistical analysis of the data, concentrations that
2759
had a significant toxic effect on one of the observed responses
2760
would not be subsequently tested for an effect on some other
2761
response. This is one reason for excluding concentrations that have
2762
shown a statistically significant reduction in survival from a
2763
subsequent hypothesis test for effects on another parameter such as
2764
reproduction. A second reason is that the exclusion of such
2765
concentrations usually results in a more powerful and appropriate
2766
statistical analysis. In performing the point estimation techniques
2767
recommended in this manual, an all-data approach is used. For
2768
example, data from concentrations above the NOEC for survival are
2769
included in determining ICp estimates using the Linear
2770
Interpolation Method.
2771
2772
2773
9.5.3
2774
ANALYSIS OF GROWTH AND REPRODUCTION DATA
2775
2776
2777
2778
2779
9.5.3.1
2780
Growth data from the sheepshead minnow, Cyprinodon
2781
variegatus, and inland silverside, Menidia beryllina, larval
2782
survival and growth tests, and the mysid, Mysidopsis bahia,
2783
survival, growth, and fecundity test, are analyzed using hypothesis
2784
testing according to the flowchart in Figure 2. The above mentioned
2785
growth data may also be analyzed by generating a point estimate
2786
with the Linear Interpolation Method. Data from effluent
2787
concentrations that have tested significantly different from the
2788
control for survival are excluded from further hypothesis tests
2789
concerning growth effects. Growth is defined as the change in dry
2790
weight of the orginal number of test organisms when group weights
2791
are obtained. When analyzing the data using point estimating
2792
techniques, data from all concentrations are included in the
2793
analysis.
2794
2795
2796
9.5.3.2
2797
Fecundity data from the mysid, Mysidopsis bahia, test may
2798
be analyzed using hypothesis testing after an arc sine
2799
transformation according to the flowchart in Figure 2. The
2800
fecundity data from the mysid test may also be analyzed by
2801
generating a point estimate with the Linear Interpolation
2802
Method.
2803
2804
2805
9.5.3.3
2806
Reproduction data from the red macroalga, Champia
2807
parvula, test are analyzed using hypothesis testing as illustrated
2808
in Figure 2. The reproduction data from the red macroalga test may
2809
also be analyzed by generating a point estimate with the Linear
2810
Interpolation Method.
2811
2812
2813
9.5.4
2814
ANALYSIS OF THE SEA URCHIN, ARBACIA PUNCTULATA,
2815
FERTILIZATION DATA
2816
2817
2818
2819
2820
2821
9.5.4.1
2822
Data from the sea urchin, Arbacia punctulata,
2823
fertilization test may be analyzed by hypothesis testing after an
2824
arc sine transformation according to the flowchart in Figure 2. The
2825
fertilization data from the sea urchin test may also be analyzed by
2826
generating a point estimate with the Linear Interpolation
2827
Method.
2828
2829
2830
9.5.5
2831
ANALYSIS OF MORTALITY DATA
2832
2833
2834
2835
2836
9.5.5.1
2837
Mortality data are analyzed by Probit Analysis, if
2838
appropriate, or other point estimation techniques, (i.e., the
2839
Spearman-Karber Method, the Trimmed Spearman-Karber Method, or the
2840
Graphical Method) (see Appendices H-K) (see discussion below). The
2841
mortality data can also be analyzed by hypothesis testing, after an
2842
arc sine square root transformation (see Appendices B-F), according
2843
to the flowchart in Figure 2.
2844
2845
2846
9.6
2847
HYPOTHESIS TESTS
2848
2849
2850
9.6.1 DUNNETT'S PROCEDURE
2851
2852
2853
9.6.1.1
2854
Dunnett's Procedure is used to determine the NOEC. The
2855
procedure consists of an analysis of variance (ANOVA) to determine
2856
the error term, which is then used in a multiple comparison
2857
procedure for comparing each of the treatment means with the
2858
control mean, in a series of paired tests (see Appendix C). Use of
2859
Dunnett's Procedure requires at least three replicates per
2860
treatment to check the assumptions of the test. In cases where the
2861
numbers of data points (replicates) for each concentration are not
2862
equal, a t test may be performed with Bonferroni's adjustment for
2863
multiple comparisons (see Appendix D), instead of using Dunnett's
2864
Procedure.
2865
2866
2867
9.6.1.2
2868
The assumptions upon which the use of Dunnett's Procedure
2869
is contingent are that the observations within treatments are
2870
normally distributed, with homogeneity of variance. Before
2871
analyzing the data, these assumptions must be tested using the
2872
procedures provided in Appendix B.
2873
2874
2875
9.6.1.3
2876
If, after suitable transformations have been carried out,
2877
the normality assumptions have not been met, Steel's Many-one Rank
2878
Test should be used if there are four or more data points
2879
(replicates) per toxicant concentration. If the numbers of data
2880
points for each toxicant concentration are not equal, the Wilcoxon
2881
Rank Sum Test with Bonferroni's adjustment should be used (see
2882
Appendix F).
2883
2884
2885
9.6.1.4
2886
Some indication of the sensitivity of the analysis should
2887
be provided by calculating (1) the minimum difference between means
2888
that can be detected as statistically significant, and (2) the
2889
percent change from the control mean that this minimum difference
2890
represents for a given test.
2891
2892
2893
9.6.1.5
2894
A step-by-step example of the use of Dunnett's Procedure
2895
is provided in Appendix C.
2896
2897
2898
9.6.2
2899
T TEST WITH THE BONFERRONI ADJUSTMENT
2900
2901
2902
2903
2904
9.6.2.1
2905
The t test with the Bonferroni adjustment is used as an
2906
alternative to Dunnett's Procedure when the number of replicates is
2907
not the same for all concentrations. This test sets an upper bound
2908
of alpha on the overall error rate, in contrast to Dunnett's
2909
Procedure, for which the overall error rate is fixed at alpha.
2910
Thus, Dunnett's Procedure is a more powerful test.
2911
2912
2913
9.6.2.2
2914
The assumptions upon which the use of the t test with the
2915
Bonferroni adjustment is contingent are that the observations
2916
within treatments are normally distributed, with homogeneity of
2917
variance. These assumptions must be tested using the procedures
2918
provided in Appendix B.
2919
2920
2921
9.6.2.3
2922
The estimate of the safe concentration derived from this
2923
test is reported in terms of the NOEC. A step-by-step example of
2924
the use of a t-test with the Bonferroni adjustment is provided in
2925
Appendix D.
2926
2927
2928
9.6.3
2929
STEEL'S MANY-ONE RANK TEST
2930
2931
2932
2933
2934
9.6.3.1
2935
Steel's Many-one Rank Test is a multiple comparison
2936
procedure for comparing several treatments with a control. This
2937
method is similar to Dunnett's procedure, except that it is not
2938
necessary to meet the assumption of normality. The data are ranked,
2939
and the analysis is performed on the ranks rather than on the data
2940
themselves. If the data are normally or nearly normally
2941
distributed, Dunnett's Procedure would be more sensitive (would
2942
detect smaller differences between the treatments and control). For
2943
data that are not normally distributed, Steel's Many-one Rank Test
2944
can be much more efficient (Hodges and Lehmann, 1956).
2945
2946
2947
9.6.3.2
2948
It is necessary to have at least four replicates per
2949
toxicant concentration to use Steel's test. Unlike Dunnett's
2950
procedure, the sensitivity of this test cannot be stated in terms
2951
of the minimum difference between treatment means and the control
2952
mean that can be detected as statistically significant.
2953
2954
2955
9.6.3.3
2956
The estimate of the safe concentration is reported as the
2957
NOEC. A step-by-step example of the use of Steel's Many-One Rank
2958
Test is provided in Appendix E.
2959
2960
2961
9.6.4
2962
WILCOXON RANK SUM TEST WITH THE BONFERRONI
2963
ADJUSTMENT
2964
2965
2966
2967
2968
9.6.4.1
2969
The Wilcoxon Rank Sum Test is a nonparametric test for
2970
comparing a treatment with a control. The data are ranked and the
2971
analysis proceeds exactly as in Steel's Test except that
2972
Bonferroni's adjustment for multiple comparisons is used instead of
2973
Steel's tables. When Steel's test can be used (i.e., when there are
2974
equal numbers of data points per toxicant concentration), it will
2975
be more powerful (able to detect smaller differences as
2976
statistically significant) than the Wilcoxon Rank Sum Test with
2977
Bonferroni's adjustment.
2978
2979
2980
9.6.4.2
2981
The estimate of the safe concentration is reported as the
2982
NOEC. A step-by-step example of the use of the Wilcoxon Rank Sum
2983
Test with Bonferroni adjustment is provided in Appendix
2984
F.
2985
2986
2987
9.6.5
2988
A CAUTION IN THE USE OF HYPOTHESIS TESTING
2989
2990
2991
2992
2993
9.6.5.1
2994
If in the calculation of an NOEC by hypothesis testing,
2995
two tested concentrations cause statistically significant adverse
2996
effects, but an intermediate concentration did not cause
2997
statistically significant effects, the results should be used with
2998
extreme caution.
2999
3000
3001
9.7
3002
POINT ESTIMATION TECHNIQUES
3003
3004
3005
9.7.1 PROBIT ANALYSIS
3006
3007
3008
9.7.1.1
3009
Probit Analysis is used to estimate an LC1, LC50, EC1, or
3010
EC50 and the associated 95% confidence interval. The analysis
3011
consists of adjusting the data for mortality in the control, and
3012
then using a maximum likelihood technique to estimate the
3013
parameters of the underlying log tolerance distribution, which is
3014
assumed to have a particular shape.
3015
3016
3017
9.7.1.2
3018
The assumption upon which the use of Probit Analysis is
3019
contingent is a normal distribution of log tolerances. If the
3020
normality assumption is not met, and at least two partial
3021
mortalities are not obtained, Probit Analysis should not be used.
3022
It is important to check the results of Probit Analysis to
3023
determine if use of the analysis is appropriate. The chi-square
3024
test for heterogeneity provides a good test of appropriateness of
3025
the analysis. The computer program (see discussion, Appendix H)
3026
checks the chi-square statistic calculated for the data set against
3027
the tabular value, and provides an error message if the calculated
3028
value exceeds the tabular value.
3029
3030
3031
9.7.1.3
3032
A discussion of Probit Analysis, and examples of computer
3033
program input and output, are found in Appendix H.
3034
3035
3036
9.7.1.4
3037
In cases where Probit Analysis is not appropriate, the
3038
LC50 and confidence interval may be estimated by the
3039
Spearman-Karber Method (Appendix I) or the Trimmed Spearman-Karber
3040
Method (Appendix J). If a test results in 100% survival and 100%
3041
mortality in adjacent treatments (all or nothing effect), the LC50
3042
may be estimated using the Graphical Method (Appendix
3043
K).
3044
3045
3046
9.7.2
3047
LINEAR INTERPOLATION METHOD
3048
3049
3050
3051
3052
9.7.2.1
3053
The Linear Interpolation Method (see Appendix L) is a
3054
procedure to calculate a point estimate of the effluent or other
3055
toxicant concentration [Inhibition Concentration, (IC)] that causes
3056
a given percent reduction (e.g., 25%, 50%, etc.) in the
3057
reproduction, growth, fertilization, or fecundity of the test
3058
organisms. The procedure was designed for general applicability in
3059
the analysis of data from short-term chronic toxicity
3060
tests.
3061
3062
3063
9.7.2.2
3064
Use of the Linear Interpolation Method is based on the
3065
assumptions that the responses (1) are monotonically non-increasing
3066
(the mean response for each higher concentration is less than or
3067
equal to the mean response for the previous concentration), (2)
3068
follow a piece-wise linear response function, and (3) are from a
3069
random, independent, and representative sample of test data. The
3070
assumption for piece-wise linear response cannot be tested
3071
statistically, and no defined statistical procedure is provided to
3072
test the assumption for monotonicity. Where the observed means are
3073
not strictly monotonic by examination, they are adjusted by
3074
smoothing. In cases where the responses at the low toxicant
3075
concentrations are much higher than in the controls, the smoothing
3076
process may result in a large upward adjustment in the control
3077
mean.
3078
3079
3080
9.7.2.3
3081
The inability to test the monotonicity and piece wise
3082
linear response assumptions for this method makes it difficult to
3083
assess when the method is, or is not, producing reliable results.
3084
Therefore, the method should be used with caution when the results
3085
of a toxicity test approach an "all or nothing" response from one
3086
concentration to the next in the concentration series, and when it
3087
appears that there is a large deviation from monotonicity. See
3088
Appendix L for a more detailed discussion of the use of this method
3089
and a computer program available for performing
3090
calculations.
3091
3092
3093
SECTION 10
3094
REPORT PREPARATION AND TEST REVIEW
3095
10.1 REPORT PREPARATION
3096
The toxicity data are reported, together with other appropriate
3097
data. The following general format and content are recommended for
3098
the report:
3099
10.1.1 INTRODUCTION
3100
3101
3102
1.
3103
Permit number
3104
3105
3106
2.
3107
Toxicity testing requirements of permit
3108
3109
3110
3.
3111
Plant location
3112
3113
3114
4.
3115
Name of receiving water body
3116
3117
3118
3119
5.
3120
Contract Laboratory (if the test was performed under
3121
contract)
3122
3123
3124
3125
a.
3126
Name of firm
3127
3128
3129
b.
3130
Phone number
3131
3132
3133
c.
3134
Address
3135
3136
3137
3138
3139
6. Objective of test
3140
10.1.2 PLANT OPERATIONS
3141
3142
3143
1.
3144
Product(s)
3145
3146
3147
2.
3148
Raw materials
3149
3150
3151
3.
3152
Operating schedule
3153
3154
3155
4.
3156
Description of waste treatment
3157
3158
3159
5.
3160
Schematic of waste treatment
3161
3162
3163
6.
3164
Retention time (if applicable)
3165
3166
3167
7.
3168
Volume of waste flow (MGD, CFS, GPM)
3169
3170
3171
8.
3172
Design flow of treatment facility at time of
3173
sampling
3174
3175
3176
10.1.3 SOURCE OF EFFLUENT, RECEIVING WATER, AND DILUTION
3177
WATER
3178
1. Effluent Samples
3179
3180
3181
a.
3182
Sampling point (including latitude and
3183
longitude)
3184
3185
3186
b.
3187
Collection dates and times
3188
3189
3190
c.
3191
Sample collection method
3192
3193
3194
d.
3195
Physical and chemical data
3196
3197
3198
e.
3199
Mean daily discharge on sample collection date
3200
3201
3202
f.
3203
Lapsed time from sample collection to delivery
3204
3205
3206
g.
3207
Sample temperature when received at the
3208
laboratory
3209
3210
3211
2. Receiving Water Samples
3212
3213
3214
a.
3215
Sampling point (including latitude and
3216
longitude)
3217
3218
3219
b.
3220
Collection dates and times
3221
3222
3223
c.
3224
Sample collection method
3225
3226
3227
d.
3228
Physical and chemical data
3229
3230
3231
e.
3232
Tide stages
3233
3234
3235
f.
3236
Sample temperature when received at the
3237
laboratory
3238
3239
3240
g.
3241
Lapsed time from sample collection to delivery
3242
3243
3244
3. Dilution Water Samples
3245
3246
3247
a.
3248
Source
3249
3250
3251
b.
3252
Collection date and time
3253
3254
3255
c.
3256
Pretreatment
3257
3258
3259
d.
3260
Physical and chemical characteristics
3261
3262
3263
10.1.4 TEST METHODS
3264
3265
3266
1.
3267
Toxicity test method used (title, number,
3268
source)
3269
3270
3271
2.
3272
Endpoint(s) of test
3273
3274
3275
3.
3276
Deviation(s) from reference method, if any, and the
3277
reason(s)
3278
3279
3280
4.
3281
Date and time test started
3282
3283
3284
5.
3285
Date and time test terminated
3286
3287
3288
6.
3289
Type of volume and test chambers
3290
3291
3292
7.
3293
Volume of solution used per chamber
3294
3295
3296
8.
3297
Number of organisms used per test chamber
3298
3299
3300
9.
3301
Number of replicate test chambers per
3302
treatment
3303
3304
3305
10.
3306
Acclimation of test organisms (temperature and salinity
3307
mean and range)
3308
3309
3310
11.
3311
Test temperature (mean and range)
3312
3313
3314
12.
3315
Specify if aeration was needed
3316
3317
3318
13.
3319
Feeding frequency, and amount and type of food
3320
3321
3322
14.
3323
Test salinity (mean and range)
3324
3325
3326
15.
3327
Specify if (and how) pH control measures were
3328
implemented
3329
3330
3331
10.1.5 TEST ORGANISMS
3332
3333
3334
1.
3335
Scientific name and how determined
3336
3337
3338
2.
3339
Age
3340
3341
3342
3.
3343
Life stage
3344
3345
3346
4.
3347
Mean length and weight (where applicable)
3348
3349
3350
5.
3351
Source
3352
3353
3354
6.
3355
Diseases and treatment (where applicable)
3356
3357
3358
7.
3359
Taxonomic key used for species identification
3360
3361
3362
10.1.6 QUALITY ASSURANCE
3363
3364
3365
1.
3366
Reference toxicant used routinely; source
3367
3368
3369
2.
3370
Date and time of most recent reference toxicant test;
3371
test results and current control (cusum) chart
3372
3373
3374
3.
3375
Dilution water used in reference toxicant test
3376
3377
3378
4.
3379
Results (NOEC or, where applicable, LOEC, LC50, EC50,
3380
IC25 and/or IC50); report percent minimum significant difference
3381
(PMSD) calculated for sublethal endpoints determined by hypothesis
3382
testing in reference toxicant test
3383
3384
3385
5.
3386
Physical and chemical methods used
3387
3388
3389
10.1.7 RESULTS
3390
3391
3392
1.
3393
Provide raw toxicity data in tabular form, including
3394
daily records of affected organisms in each concentration
3395
(including controls) and replicate, and in graphical form (plots of
3396
toxicity data)
3397
3398
3399
2.
3400
Provide table of LC50s, NOECs, IC25, IC50, etc. (as
3401
required in the applicable NPDES permit)
3402
3403
3404
3.
3405
Indicate statistical methods to calculate
3406
endpoints
3407
3408
3409
4.
3410
Provide summary table of physical and chemical
3411
data
3412
3413
3414
5.
3415
Tabulate QA data
3416
3417
3418
6.
3419
Provide percent minimum significant difference (PMSD)
3420
calculated for sublethal endpoints
3421
3422
3423
10.1.8 CONCLUSIONS AND RECOMMENDATIONS
3424
3425
3426
1.
3427
Relationship between test endpoints and permit
3428
limits.
3429
3430
3431
2.
3432
Action to be taken.
3433
3434
3435
10.2 TEST REVIEW
3436
3437
3438
10.2.1
3439
Test review is an important part of an overall quality
3440
assurance program (Section 4) and is necessary for ensuring that
3441
all test results are reported accurately. Test review should be
3442
conducted on each test by both the testing laboratory and the
3443
regulatory authority.
3444
3445
3446
10.2.2
3447
SAMPLING AND HANDLING
3448
3449
3450
3451
3452
10.2.2.1
3453
The collection and handling of samples are reviewed to
3454
verify that the sampling and handling procedures given in Section 8
3455
were followed. Chain-of-custody forms are reviewed to verify that
3456
samples were tested within allowable sample holding times
3457
(Subsection 8.5.4). Any deviations from the procedures given in
3458
Section 8 should be documented and described in the data report
3459
(Subsection 10.1).
3460
3461
3462
10.2.3
3463
TEST ACCEPTABILITY CRITERIA
3464
3465
3466
3467
3468
10.2.3.1
3469
Test data are reviewed to verify that test acceptability
3470
criteria (TAC) requirements for a valid test have been met. Any
3471
test not meeting the minimum test acceptability criteria is
3472
considered invalid. All invalid tests must be repeated with a newly
3473
collected sample.
3474
3475
3476
10.2.4
3477
TEST CONDITIONS
3478
3479
3480
3481
3482
10.2.4.1
3483
Test conditions are reviewed and compared to the
3484
specifications listed in the summary of test condition tables
3485
provided for each method. Physical and chemical measurements taken
3486
during the test (e.g., temperature, pH, and DO) also are reviewed
3487
and compared to specified ranges. Any deviations from
3488
specifications should be documented and described in the data
3489
report (Subsection 10.1).
3490
3491
3492
10.2.4.2
3493
The summary of test condition tables presented for each
3494
method identify test conditions as required or recommended. For WET
3495
test data submitted under NPDES permits, all required test
3496
conditions must be met or the test is considered invalid and must
3497
be repeated with a newly collected sample. Deviations from
3498
recommended test conditions must be evaluated on a case-by-case
3499
basis to determine the validity of test results. Deviations from
3500
recommended test conditions may or may not invalidate a test result
3501
depending on the degree of the departure and the objective of the
3502
test. The reviewer should consider the degree of the deviation and
3503
the potential or observed impact of the deviation on the test
3504
result before rejecting or accepting a test result as valid. For
3505
example, if dissolved oxygen is measured below 4.0 mg/L in one test
3506
chamber, the reviewer should consider whether any observed
3507
mortality in that test chamber corresponded with the drop in
3508
dissolved oxygen.
3509
3510
3511
10.2.4.3
3512
Whereas slight deviations in test conditions may not
3513
invalidate an individual test result, test condition deviations
3514
that continue to occur frequently in a given laboratory may
3515
indicate the need for improved quality control in that
3516
laboratory.
3517
3518
3519
10.2.5
3520
STATISTICAL METHODS
3521
3522
3523
10.2.5.1 The statistical methods used for analyzing test data
3524
are reviewed to verify that the recommended flowcharts for
3525
statistical analysis were followed. Any deviation from the
3526
recommended flowcharts for selection of statistical methods should
3527
be noted in the data report. Statistical methods other than those
3528
recommended in the statistical flowcharts may be appropriate (see
3529
Subsection 9.4.1.2), however, the laboratory must document the use
3530
of and provide the rationale for the use of any alternate
3531
statistical method. In all cases (flowchart recommended methods or
3532
alternate methods), reviewers should verify that the necessary
3533
assumptions are met for the statistical method used.
3534
10.2.6 CONCENTRATION-RESPONSE RELATIONSHIPS
3535
3536
3537
10.2.6.1
3538
The concept of a concentration-response, or more
3539
classically, a dose-response relationship is "the most fundamental
3540
and pervasive one in toxicology" (Casarett and Doull, 1975). This
3541
concept assumes that there is a causal relationship between the
3542
dose of a toxicant (or concentration for toxicants in solution) and
3543
a measured response. A response may be any measurable biochemical
3544
or biological parameter that is correlated with exposure to the
3545
toxicant. The classical concentration-response relationship is
3546
depicted as a sigmoidal shaped curve, however, the particular shape
3547
of the concentration-response curve may differ for each coupled
3548
toxicant and response pair. In general, more severe responses (such
3549
as acute effects) occur at higher concentrations of the toxicant,
3550
and less severe responses (such as chronic effects) occur at lower
3551
concentrations. A single toxicant also may produce multiple
3552
responses, each characterized by a concentration-response
3553
relationship. A corollary of the concentration-response concept is
3554
that every toxicant should exhibit a concentration-response
3555
relationship, given that the appropriate response is measured and
3556
given that the concentration range evaluated is appropriate. Use of
3557
this concept can be helpful in determining whether an effluent
3558
possesses toxicity and in identifying anomalous test
3559
results.
3560
3561
3562
10.2.6.2
3563
The concentration-response relationship generated for
3564
each multi-concentration test must be reviewed to ensure that
3565
calculated test results are interpreted appropriately. USEPA
3566
(2000a) provides guidance on evaluating concentration-response
3567
relationships to assist in determining the validity of WET test
3568
results. All WET test results (from multi-concentration tests)
3569
reported under the NPDES program should be reviewed and reported
3570
according to USEPA guidance on the evaluation of
3571
concentration-response relationships (USEPA, 2000a). This guidance
3572
provides review steps for 10 different concentration-response
3573
patterns that may be encountered in WET test data. Based on the
3574
review, the guidance provides one of three determinations: that
3575
calculated effect concentrations are reliable and should be
3576
reported, that calculated effect concentrations are anomalous and
3577
should be explained, or that the test was inconclusive and the test
3578
should be repeated with a newly collected sample. It should be
3579
noted that the determination of a valid concentration-response
3580
relationship is not always clear cut. Data from some tests may
3581
suggest consultation with professional toxicologists and/or
3582
regulatory officials. Tests that exhibit unexpected
3583
concentration-response relationships also may indicate a need for
3584
further investigation and possible retesting.
3585
3586
3587
10.2.7
3588
REFERENCE TOXICANT TESTING
3589
3590
3591
3592
3593
10.2.7.1
3594
Test review of a given effluent or receiving water test
3595
should include review of the associated reference toxicant test and
3596
current control chart. Reference toxicant testing and control
3597
charting is required for documenting the quality of test organisms
3598
(Subsection 4.7) and ongoing laboratory performance (Subsection
3599
4.16). The reviewer should verify that a quality control reference
3600
toxicant test was conducted according to the specified frequency
3601
required by the permitting authority or recommended by the method
3602
(e.g., monthly). The test acceptability criteria, test conditions,
3603
concentration-response relationship, and test sensitivity of the
3604
reference toxicant test are reviewed to verify that the reference
3605
toxicant test conducted was a valid test. The results of the
3606
reference toxicant test are then plotted on a control chart (see
3607
Subsection 4.16) and compared to the current control chart limits
3608
(± 2 standard deviations).
3609
3610
3611
10.2.7.2
3612
Reference toxicant tests that fall outside of recommended
3613
control chart limits are evaluated to determine the validity of
3614
associated effluent and receiving water tests (see Subsection
3615
4.16). An out of control reference toxicant test result does not
3616
necessarily invalidate associated test results. The reviewer should
3617
consider the degree to which the reference toxicant test result
3618
fell outside of control chart limits, the width of the limits, the
3619
direction of the deviation (toward increasing test organism
3620
sensitivity or toward decreasing test organism sensitivity), the
3621
test conditions of both the effluent test and the reference
3622
toxicant test, and the objective of the test. More frequent and/or
3623
concurrent reference toxicant testing may be advantageous if recent
3624
problems (e.g., invalid tests, reference toxicant test results
3625
outside of control chart limits, reduced health of organism
3626
cultures, or increased within-test variability) have been
3627
identified in testing.
3628
3629
3630
10.2.8
3631
TEST VARIABILITY
3632
3633
3634
3635
3636
10.2.8.1
3637
The within-test variability of individual tests should be
3638
reviewed. Excessive within-test variability may invalidate a test
3639
result and warrant retesting. For evaluating within-test
3640
variability, reviewers should consult EPA guidance on upper and
3641
lower percent minimum significant difference (PMSD) bounds (USEPA,
3642
2000b).
3643
3644
3645
10.2.8.2
3646
When NPDES permits require sublethal hypothesis testing
3647
endpoints from Methods 1006.0 or 1007.0 (e.g., growth NOECs and
3648
LOECs), within-test variability must be reviewed and variability
3649
criteria must be applied as described in this section (10.2.8.2).
3650
When the methods are used for non-regulatory purposes, the
3651
variability criteria herein are recommended but are not required,
3652
and their use (or the use of alternative variability criteria) may
3653
depend upon the intended uses of the test results and the
3654
requirements of any applicable data quality objectives and quality
3655
assurance plan.
3656
3657
3658
3659
3660
10.2.8.2.1
3661
To measure test variability, calculate the percent
3662
minimum significant difference (PMSD) achieved in the test. The
3663
PMSD is the smallest percentage decrease in growth or reproduction
3664
from the control that could be determined as statistically
3665
significant in the test. The PMSD is calculated as 100 times the
3666
minimum significant difference (MSD) divided by the control mean.
3667
The equation and examples of MSD calculations are shown in Appendix
3668
C. PMSD may be calculated legitimately as a descriptive statistic
3669
for within-test variability, even when the hypothesis test is
3670
conducted using a non-parametric method. The PMSD bounds were based
3671
on a representative set of tests, including tests for which a
3672
non-parametric method was required for determining the NOEC or
3673
LOEC. The conduct of hypothesis testing to determine test results
3674
should follow the statistical flow charts provided for each method.
3675
That is, when test data fail to meet assumptions of normality or
3676
heterogeneity of variance, a non-parametric method (determined
3677
following the statistical flowchart for the method) should be used
3678
to calculate test results, but the PMSD may be calculated as
3679
described above (using parametric methods) to provide a measure of
3680
test variability.
3681
3682
3683
10.2.8.2.2
3684
Compare the PMSD measured in the test with the upper PMSD
3685
bound variability criterion listed in Table 6. When the test PMSD
3686
exceeds the upper bound, the variability among replicates is
3687
unusually large for the test method. Such a test should be
3688
considered insufficiently sensitive to detect toxic effects on
3689
growth or reproduction of substantial magnitude. A finding of
3690
toxicity at a particular concentration may be regarded as
3691
trustworthy, but a finding of "no toxicity" or "no statistically
3692
significant toxicity" at a particular concentration should not be
3693
regarded as a reliable indication that there is no substantial
3694
toxic effect on growth or reproduction at that
3695
concentration.
3696
3697
3698
10.2.8.2.3
3699
If the PMSD measured for the test is less than or equal
3700
to the upper PMSD bound variability criterion in Table 6, then the
3701
test's variability measure lies within normal bounds and the effect
3702
concentration estimate (e.g., NOEC or LOEC) would normally be
3703
accepted unless other test review steps raise serious doubts about
3704
its validity.
3705
3706
3707
10.2.8.2.4
3708
If the PMSD measured for the test exceeds the upper PMSD
3709
bound variability criterion in Table 6, then one of the following
3710
two cases applies (10.2.8.2.4.1, 10.2.8.2.4.2).
3711
3712
3713
3714
3715
10.2.8.2.4.1
3716
If toxicity is found at the permitted receiving water
3717
concentration (RWC) based upon the value of the effect
3718
concentration estimate (NOEC or LOEC), then the test shall be
3719
accepted and the effect concentration estimate may be reported,
3720
unless other test review steps raise serious doubts about its
3721
validity.
3722
3723
3724
10.2.8.2.4.2
3725
If toxicity is not found at the permitted RWC based upon
3726
the value of the effect concentration estimate (NOEC or LOEC) and
3727
the PMSD measured for the test exceeds the upper PMSD bound, then
3728
the test shall not be accepted, and a new test must be conducted
3729
promptly on a newly collected sample.
3730
3731
3732
10.2.8.2.5
3733
To avoid penalizing laboratories that achieve unusually
3734
high precision, lower PMSD bounds shall also be applied when a
3735
hypothesis test result (e.g., NOEC or LOEC) is reported. Lower PMSD
3736
bounds, which are based on the 10th percentiles of national PMSD
3737
data, are presented in Table 6. The 10th percentile PMSD represents
3738
a practical limit to the sensitivity of the test method because few
3739
laboratories are able to achieve such precision on a
3740
3741
3742
regular basis and most do not achieve it even occasionally. In
3743
determining hypothesis test results (e.g., NOEC or LOEC), a test
3744
concentration shall not be considered toxic (i.e., significantly
3745
different from the control) if the relative difference from the
3746
control is less than the lower PMSD bounds in Table 6. See USEPA,
3747
2000b for specific examples of implementing lower PMSD bounds.
3748
10.2.8.3 To assist in reviewing within-test variability, EPA
3749
recommends maintaining control charts of PMSDs calculated for
3750
successive effluent tests (USEPA, 2000b). A control chart of PMSD
3751
values characterizes the range of variability observed within a
3752
given laboratory, and allows comparison of individual test PMSDs
3753
with the laboratory's typical range of variability. Control charts
3754
of other variability and test performance measures, such as the
3755
MSD, standard deviation or CV of control responses, or average
3756
control response, also may be useful for reviewing tests and
3757
minimizing variability. The log of PMSD will provide an
3758
approximately normal variate useful for control charting.
3759
TABLE 6. VARIABILITY CRITERIA (UPPER AND LOWER PMSD BOUNDS) FOR
3760
SUBLETHAL HYPOTHESIS TESTING ENDPOINTS SUBMITTED UNDER NPDES
3761
PERMITS.1
3762
3763
Lower and upper PMSD bounds were determined from the 10th and
3764
90th percentile, respectively, of PMSD data from EPA's WET
3765
Interlaboratory Variability Study (USEPA, 2001a; USEPA, 2000b).
3766
3767
3768
3769
3770
3771